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Summary:
Author: Avneesh Kumar
Thesis title: Oxidative stress on human proximal tubular cells in 
ischemia-reperfusion injury
Renal transplantation can often be complicated due to delayed graft function 
which is a direct sequela of ischemia reperfusion injury. Reactive oxygen 
species are the key mediators in this process causing direct cell damage 
which also initiate inflammation by inducing chemokines. The adverse 
outcome of delayed graft function is not only short term but long term function 
of the graft is also affected. The aim of this study was to measure the 
oxidative stress response in a cell culture system (immortalised human 
proximal renal tubular cells, HK-2) in response to a simulated pathological 
condition of ischemia reperfusion injury. The ability of these cells to produce 
chemokines in response to oxidative stress was also determined. Incubation 
with 0.5mM hydrogen peroxide produced a significant increase in the activity 
of the antioxidant enzyme glutathione peroxidase. Chemokines lnterleukin-8 
(IL-8; CXCL8) and MCP-1 (CCL2) were also induced after incubation with 
hydrogen peroxide. A dose related response was also observed. The 
cytokine lnterleukin-1 (3 (IL-1p) at 1ng/ml significantly potentiated the 
expression of both IL-8 (CXCL8) and MCP-1 (CCL2). Pre-incubation with an 
anti-oxidant (N-acetyl cysteine) strongly suppressed the induction of both IL-8 
and MCP-1 when stimulated with hydrogen peroxide and IL-ip. In addition, 
enzymes concerned with detoxifying reactive oxygen intermediates were 
examined in renal transplant biopsies by Western blotting. Levels were
generally increased, though not significantly, in most biopsies, irrespective of 
diagnosis, but were also raised in pre-transplant kidney biopsies. This study 
identifies the role of oxidant injury in ischemia reperfusion injury and shows 
the underlying mechanisms of chemokine induction and suppression in 
oxidative stress. It also opens a new therapeutic window for anti-oxidants like 
N-acetyl cysteine in ameliorating this injury. These findings can have 
potential implications for clinical use to prevent ischemia reperfusion injury in 
renal transplantation.
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INTRODUCTION AND REVIEW OF 
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18
The kidneys are complicated organs that have numerous biological roles. 
The anatomical design of the kidney and its functional unit, the nephron, 
provides the primary route for the elimination of the end products of 
metabolism and of ingested foreign substances. Of equal or greater 
importance, however, is the role that the kidney plays in the regulation of 
extracellular fluid volume, osmolarity, pH and electrolyte composition. 
Approximately one fifth of the cardiac output passes through the kidneys 
resulting in renal blood flow of up to 400ml per 100g of kidney per minute; a 
total of 170-180 L of plasma per day is filtered through the glomeruli at an 
approximate rate of 125ml/min (Raftery, 2000).
1.1 Anatomy of Kidney:
The kidneys are paired retroperitoneal organs situated on the posterior wall 
of the abdomen on each side of the vertebral column, at about the level of 
the twelfth rib. The left kidney is slightly higher in the abdomen than the right, 
due to the presence of the liver displacing the right kidney down. The normal 
kidney size of an adult human is about 12 x 6 x 3 cm with a weight of about 
130gm (Mc-Minn, 1990). Cross section of a kidney shows a pale outer 
region, the cortex, and a darker inner region, the medulla (Figure 1).
The medulla is divided into 8-18 conical regions, called the renal pyramids; 
the base of each pyramid starts at the corticomedullary border, and the apex 
ends in the renal papilla which merges to form the renal pelvis and then on to 
form the ureter.
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Figure 1.1: Cross section of the right kidney showing the major blood 
vessels.
(Human body: cross section of right kidney. Art. Encyclopaedia Britannica 
Online)
1.2 Microscopic structure:
The nephron (Figure 2) is the basic functional unit of the kidney. Each kidney 
contains approximately 200,000 to over 1.8 million nephrons (Hoy et al, 
2003). Each nephron is made up of glomerulus, proximal convoluted tubule, 
loop of Henle and distal convoluted tubule.
1.2.1 Glomerulus is made up of a tuft of capillaries which invaginates into
the proximal blind end of the nephron called Bowman’s capsule. The
20
epithelium covering the capillaries is continuous with that over the Bowman’s 
capsule. The endothelium of the glomerulus is fenestrated with pores that are 
70-90 nm in diameter and the epithelial cells have numerous pseudopodia 
that interdigitate to form filtration slits. The glomerular membrane acts as the 
main filtration mechanism and is impermeable to molecules larger than 4nm 
diameter (Ganong, 2001).
1.2.2 The proximal convoluted tubule is adjacent to Bowman’s capsule 
and is responsible for controlled absorption of glucose and sodium, other 
solutes are also absorbed in this region.
1.2.3 The loop of Henle is the convoluted part of the proximal tubule which 
continues into the distal convoluted tubule. The thin descending limb is made 
of flattened cells whilst the ascending part is thick and made up of cuboidal 
cells. This region is responsible for concentration and dilution of urine by 
utilising a counter-current multiplying mechanism. It is water-impermeable but 
can pump sodium out, which in turn affects the osmolarity of the surrounding 
tissues and will affect the subsequent movement of water in or out of the 
water-permeable collecting duct.
1.2.4 The distal convoluted tubule is about 5mm long with few microvilli 
and has no distinct brush border. This region is responsible, along with the 
collecting duct that it joins, for absorbing water back into the body. 99% of the 
water is normally reabsorbed, leaving highly concentrated urine to flow into 
the collecting duct and then into the renal pelvis.
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Figure 1.2: Nephron, the functional unit of kidney (20th U.S. edition of 
Gray's Anatomy of the Human Body)
1.3 Physiology:
The functions of the kidney can be divided into two groups: Endocrine 
function and extracellular homeostasis.
1.3.1 Endocrine function:
1. Secretion of erythropoietin, which regulates red blood cell production in the 
bone marrow.
2. Secretion of renin, which is a key part of the renin-angiotensin-aldosterone 
system.
3. Secretion of the active form of vitamin-D (Calcitriol) and prostaglandins.
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1.3.2 Extracellular homeostasis:
The kidney's ability to perform many of its excretory functions depends on the 
three fundamental functions of filtration, re-absorption and secretion.
1.3.2.1 Filtration
The blood is filtered by nephrons, the functional units of the kidney. The 
glomerular filtration barrier, responsible for the size and charge-selective 
properties of renal filter, is composed of three separate layers: the 
fenestrated endothelium, the glomerular basement membrane (GBM), and 
the podocyte foot processes layer. Glomerular podocytes are highly 
differentiated cells with a complex cytoarchitecture. They have a voluminous 
cell body, long primary processes and regularly spaced, interdigitated foot 
processes that completely enwrap the glomerular capillaries (Gigante et al, 
2011). The interdigitated foot processes of neighbouring podocytes cover the 
GBM and form a narrow filtration slit connected by an electron dense 
structure, called the slit diaphragm, a structure with a 40 nm diameter 
(Karnovsky and Ainsworth, 1972). The negative charge of the GBM was 
thought to provide a barrier to macromolecules (Kanwar, Linker and 
Farquhar, 1980) but instead a key role of podocytes has been described 
(Tryggvason, Patrakka and Wartiovaara, 2006), (Patrakka and Tryggvason, 
2009). Cells, proteins, and other large molecules are filtered out of the 
glomerulus by a process of ultra filtration, leaving an ultra filtrate that 
resembles plasma (except that the ultra filtrate has negligible plasma 
proteins) to enter Bowman's space. Filtration is driven by Starling’s force. 
The ultra filtrate is passed, in turn, through the proximal tubule, the loop of
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Henle, the distal convoluted tubule, and a series of collecting ducts to form 
urine.
1.4 Proximal tubular cells (PTC):
The epithelial cells of the proximal tubule are also continuous with the 
epithelial cells of Bowman’s capsule, but they differ in their morphology. The 
human PCT is about 15 mm long and 55 pm in diameter (Ganong, 2001). 
The cells lining the proximal tubule are cuboidal epithelial cells with deep 
basal membrane invaginations that provide a large basal surface area. The 
long microvilli (the brush border) lining the tubule lumen, maximize luminal 
surface area and make these cells ideally suited for both reabsorptive and 
secretory functions.
Furthermore the leaky nature of the apical tight junctions facilitates the para- 
cellular transport of water by osmosis, of solutes moving down 
electrochemical concentration gradients and of solutes moving by solvent 
drag.
Located in the luminal and basolateral membranes are enzymatic and protein 
carriers, primary and secondary active transport systems, which together with 
its permeability characteristics, make the proximal tubule the major site of re­
absorption of the glomerular filtrate. It has been estimated that under normal 
circumstances 60 to 70 % of the glomerular filtrate is reabsorbed in the 
proximal tubule. The proximal tubule is further characterized by its leaky tight 
junctions and high permeability to water, by isosmotic reabsorption of filtrate 
under all conditions, by the relatively constant fraction of filtrate reabsorbed 
and by its being the site of origin of osmotic diuresis. The principal driving 
force for this large reabsorptive capacity is the primary active transport of Na+
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across the basolateral membrane of the epithelial cell. This mechanism is 
frequently referred to as the Na+ pump. In the early proximal tubule this 
active movement of positive charge out of the tubule generates an electrical 
gradient which contributes to the driving force for the reabsorption of anions. 
The primary active transport of Na+ across the basolateral membrane of the 
epithelial cell maintains a low intracellular Na+ concentration relative to that in 
plasma and filtrate.
The Na+ gradient across the luminal membrane provides energy for 
secondary active transport of a variety of filtered solutes. The re-absorption 
of solute establishes an osmotic gradient which, due to the high water 
permeability of the proximal tubule, drives the reabsorption of water at a rapid 
rate. The movement of water out of the tubule increases the luminal 
concentration of certain substances which are permeant but not actively 
transported, thus facilitating their passive re-absorption.
The proximal tubules (especially, the straight, distal portion or S3 segment) 
located in the outer medulla of the kidney are the primary site of injury in 
renal ischemia and reperfusion (Spiegel, Shanley and Molitoris, 1990). This 
region is marginally oxygenated under normal physiological conditions, with a 
high basal metabolic demand (Chen, Edwards and Layton, 2010; 
Whitehouse et al, 2006).
Therefore, with hypoxic or ischemic insult, proximal tubules in the outer 
medullary zone suffer the most damage. Such an ischemic injury, in the 
clinical world often leads to acute kidney injury. It also leads to delayed or 
non-functioning of transplanted kidneys.
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1.5 Aquaporins: Aquaporins (AQP) are membrane water channels present 
in all life forms that play critical roles in controlling the water contents of cells 
(Borgnia et al, 1999). They permeate water, but block the transport of protons 
(Tajkhorshid et al, 2002). Eleven human AQPs have been identified, and 
their impaired function is implicated in pathological situations, such as 
nephrogenic diabetes insipidus (Borgnia et al, 1999).
2. Renal transplantation:
2.1 Introduction:
Renal transplantation offers patients with end stage renal failure improved 
survival and quality of life compared with dialysis. Not only it is the most 
physiological renal replacement therapy but it is also the most cost effective 
treatment. Although more transplants are being performed the size of the 
renal transplant waiting list is increasing at a faster rate. Data from the UK 
Renal Registry shows that since year 2000 there has been a 5% annual 
increase in prevalence of people requiring renal replacement therapy 
amounting to 2% of the total National Health Service budget (Galliford and 
Game, 2009). UK transplant is trying to increase the number of organ 
donations by improving the consent rate.
Overall long term graft survival and patient survival have remained 
unchanged since 1995. This lack of improvement has been shown, in spite of 
reduced early and late acute rejection rates (Meier-Kriesche et al, 2004) 
resulting in 5- and 10-yr graft survival rates of 70 and 50%, respectively 
(Gourishankar and Halloran, 2002).
The most common clinical correlate of late allograft loss is referred to non- 
specifically as interstitial fibrosis and tubular atrophy (IFTA), and more than
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40% of kidney allograft recipients suffer from this during 5 yr after 
transplantation (Chapman, O'Connell and Nankivell, 2005).
IFTA is characterized by progressive renal allograft dysfunction with 
histopathoiogical features of chronic interstitial fibrosis, tubular atrophy, 
vascular occlusive changes, and glomerulosclerosis. Thus, IFTA is a 
clinicopathological classification caused by multiple factors, including 
alloantigen-dependent immune responses, as well as nonimmunological 
factors, such as ischemia-reperfusion injury (IRI), calcineurin inhibitor 
nephrotoxicity, metabolic and cardiovascular disorders, and exacerbating 
pre-existing donor disease (Chapman, O'Connell and Nankivell, 2005).
2.11 Delayed graft function:
Delayed graft function (DGF) is a well-known complication affecting the 
kidney allograft in the immediate post-transplantation period. It is a form of 
acute renal failure resulting in post-transplantation oliguria, increased 
allograft immunogenicity and risk of acute rejection episodes, and decreased 
long-term survival. The frequency of DGF ranges from 5 to 50% in 
deceased-donor kidney transplants (Yarlagadda et al, 2009). DGF is usually 
the result of predominant ischemic injury to the graft before and during 
procurement and is further aggravated by the reperfusion syndrome. There 
are several risk factors that determine the incidence of DGF including: 
kidneys from non-heart-beating donor, inotropic support of the donor, cold 
storage preservation, cold ischemia time, donor age (>55 years), marginal 
kidneys from diabetic or hypertensive donors (Perico et al, 2004).
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During the period of DGF the renal allograft remains quiescent and the 
patient requires dialysis support during this period. Patients require 
prolonged hospitalisation thus increasing the cost of transplantation and this 
also has an adverse effect on the rehabilitation of transplant recipients. 
Meta-analysis by Yarlagadda et al showed that patients with DGF had a 41 % 
increased risk of graft loss and that patients with DGF had a higher mean 
serum creatinine. DGF was also associated with a 38% relative increase in 
the risk of acute rejection (Yarlagadda et al, 2009). Acute rejection of the 
allograft results from an increased expression of major histocompatibility 
complex (MHC) class I and II molecules in the kidney due to ischemic injury 
(Shoskes and Halloran, 1996). Several other authors have also a supported 
this view that DGF increases the incidence of acute rejection (McLaren et al, 
1999), (Jushinskis et al, 2009).
Direct allorecognition is defined as the recognition by recipient I cells of 
intact MHC alloantigens displayed at the surface of donor dendritic cells 
carried within the graft. No other cells intervene in this initial step of the 
direct pathway (Land 2011).
In the indirect pathway of allorecognition, allogeneic MHC molecules and/or 
other donor alloantigen are processed and presented by recipient antigen 
presenting cells. The direct pathway plays a major role in the early weeks 
after transplantation and the indirect pathway may contribute to the process 
of chronic rejection (Hornick, 2006).
Apart from short term effects of DGF there is enough evidence accumulating 
in the literature about its deleterious effect on long term graft function and
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survival (Giral-Classe et al, 1998), (Hassanain et al, 2009), (Yarlagadda et al, 
2009).
Populations of renal ceils after recovery from the initial injury might acquire a 
programmed tendency to proliferate, synthesise matrix, or otherwise 
contribute to chronic fibrosis. Inability of the kidney cells to regenerate 
completely, as seen in several animal studies of acute tubular necrosis, then 
will have reduced survival due to reduced nephron mass (Barrientos et al, 
1994). These experimental results lend support to the finding that, in kidney- 
transplant recipients, delayed graft function is a risk factor for long-term renal 
allograft survival. Halloran et al have reported that the half-life of cadaveric 
kidneys with no delayed graft function was 1T5 years, compared with 7.2 
years for those with delayed function (Halloran and Hunsicker, 2001).
The lengthening waiting list for renal transplantation has led to a relaxation 
in the selection criteria for kidney donors and the use of kidneys from so- 
called marginal donors. There is no widely accepted definition of what 
constitutes a marginal kidney, but examples include donors at the extremes 
of age, those with longstanding hypertension or diabetes, or donors where 
there is an increased risk of disease transmission. As might be expected, 
the results of transplantation with marginal kidneys are inferior to those with 
standard kidneys (Audard et al, 2008), (Ojo et al, 2001).
Kidneys from ‘expanded criteria donors’ and kidneys donated after cardiac 
death both are associated with a higher incidence of DGF and it is expected 
to become more clinically important in the near future. This makes a 
compelling case to investigate DGF further and to find novel solutions to 
ameliorate this phenomenon.
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2.2 Oxidative stress:
Aerobic life depends upon controlled combustion for energy supply. 
Controlled combustion is catalyzed and regulated by metabolic machinery 
that can be damaged by uncontrolled oxidative reactions associated with 
energy production. Because of the extreme threat of such uncontrolled 
oxidation, aerobic life evolved a complex set of antioxidant systems to control 
these reactions and repair or replace the damaged machinery. At the same 
time, enzyme systems evolved to produce reactive species for biological 
signaling, biosynthetic reactions, chemical defence, and detoxification 
functions. The presence of both toxic and beneficial consequences of 
reactive species precludes a simple definition of oxidative stress (Jones, 
2006). Oxidative stress was a term first described in 1985 by Helmut Sies 
(Sies, 1991) as “a disturbance in the pro-oxidant - antioxidant balance in 
favour of the former.” However, it is important that the reactions in which free 
radicals are involved are not necessarily deleterious; on the contrary, they 
are of fundamental importance for life in that they take part in key 
biochemical reactions in all living organisms more useful contemporary 
definition is “a disruption of redox signaling and control” (Jones, 2006). 
Reactive oxygen intermediates can influence the signaling of a wide variety 
of kinase pathways, such as the MARK, NF-kB, CaMK and RISK pathways 
(di Mari, Davis and Safirstein, 1999). These kinase pathways can have both 
anti-apoptotic and apoptotic roles (McCubrey and Franklin, 2006).
Neutrophil activation has been gaining attention in the past several years, 
primarily due to re-evaluation of the role of excessive inflammatory response 
in kidney ischemia reperfusion injury (IRI). In models of renal IRI, depletion of
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neutrophils, blockade of neutrophil adhesion to the endothelium, and 
inhibition of the complement system all decrease kidney damage (Linfert, 
Chowdhry and Rabb, 2009). Recent studies have also indicated that ROS 
can participate in neutrophil recruitment by up-regulation of adhesion 
molecules and chemotactic factors.
Land et al have shown that such changes in chemokine and chemokine- 
receptor expression following transplantation regulate the migration of 
leukocytes from the peripheral circulation into an allograft (Land 2011). 
Appropriate alloreactivity in vivo requires leukocyte interactions controlled 
within secondary lymphoid organs, and the migration of dendritic cells from 
the allograft into secondary lymphoid tissue is of paramount importance to 
the rejection process. In transplanted organs, ischemia /reperfusion, Toll like 
receptor (TLR) activation, cytokine stimulation and complement activation all 
induce expression of multiple pro-inflammatory chemokines in the grafts. 
These changes escalate IRI and amplify allograft rejection. Activation of 
TLR’s on graft stromal cells initiates an inflammatory response characterized 
by the recruitment of cells to the sites of injury or infection by a tightly 
controlled sequence of events. This includes the expression of selectin, 
chemokine and chemokine-receptor genes that regulate cell migration to the 
sites of inflammation (Lutz, Thurmel and Heemann, 2010).
Key inflammatory chemokines induced include interleukin 8 (IL-8/CXCL8), 
growth-related oncogene (GRO/CXCL1), monocyte chemoattractant protein 
1 (MCP-1/CCL2), MCP-2 (CCL8), MCP-3 (CCL7), MCP-4 (CCL13), 
macrophage inflammatory protein, (MIP-1a/CCL3, MIP-1p/CCL4) and 
RANTES (CCL5) (Zlotnik and Yoshie, 2000).
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Oxidative stress is also shown to be increased in patients with chronic renal 
allograft nephropathy (CAN) (Raj et al, 2004).
During solid organ transplantation, both warm and cold ischemia are often 
unavoidable but can be minimized. To date, no specific therapy exists for the 
prevention or treatment of IRI. Treatment of IRI injury is still only supportive. 
Therefore, it is essential to develop preventive or therapeutic interventions 
and gain knowledge of the underlying mechanisms to prevent or reduce renal 
tissue injury following IRI.
2.3 Ischemia reperfusion injury:
Ischemia-reperfusion injury (IRI) is a common and important clinical problem 
in many different organ systems. It leads to tissue and organ damage after 
myocardial infarction, stroke, acute kidney injury, hepatic shock, mesenteric 
ischemia, and systemic shock. IRI is also common after deceased donor 
solid organ transplantation.
Cerra et al were among the first to describe reperfusion injury in 1975 in a 
canine model. They examined myocardial pedicles to detect the extent of 
reperfusion injury and found that increased ischemic times were associated 
with increased subendothelial hemorrhagic necrosis (Cerra et al, 1975). 
Hemorrhagic shock leading to ischemic reperfusion injury has been shown to 
seriously damage the gut barrier, which included injury and atrophy in 
intestinal mucosa and increasing intestinal permeability (Chang et al, 2005). 
IRI also affects the size and final outcome in cerebral and myocardial 
infarction (Boys et al, 2010).
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IRI is a common problem that occurs when blood flow is interrupted to the 
kidney in case of kidney transplantation, aortic cross clamping and shock 
with subsequent resuscitation (Hussein et al, 2011). Hypothermic kidney 
storage before transplantation adds to ischemic tissue damage. 
Ischemia-reperfusion injury is now recognized as a highly complex cascade 
of events that includes interactions between vascular endothelium, interstitial 
compartments, circulating cells, and numerous biochemical entities. 
Inflammation is known to be a key mediator of IRI and considerable data 
exist demonstrating the significance of innate immunity (Boros and 
Bromberg, 2006), (Huang, Rabb and Womer, 2007).
The final stage of ischemic injury occurs during reperfusion. Reperfusion 
injury, the effector phase of ischemic injury, develops hours or days after the 
initial insult. Repair and regeneration processes occur together with cellular 
apoptosis, autophagy, and necrosis; the fate of the organ depends on 
whether cell death or regeneration prevails (Kosieradzki and Rowinski, 
2008).
It is well established that a substantial component of post- ischemic injury is 
produced by oxygen-derived free radicals generated from xanthine oxidase 
at reperfusion. The absence of oxygen and nutrients from blood creates a 
condition in which the restoration of circulation results in production of 
Reactive Oxygen Species (ROS). Oxidative damage from the ROS recruits 
polymorphs and lymphocytes at the site of injury and produces an 
inflammation like state. The polymorphs themselves increase the generation 
of ROS and also cause direct cellular injury rather than restoration of normal 
function.
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Free radical-mediated injury releases proinflammatory cytokines and 
activates innate immunity. It has been suggested that all of these changes, 
the early innate response and the ischemic tissue damage, play roles in the 
development of adaptive responses, which in turn may lead to acute kidney 
rejection.
2.3.1 Pathophysiology of IRI:
Cellular hypoxia leads to depletion of energy and its substrates like 
Adenosine-5’-triphoshate (ATP) and Adenosine diphoshate (ADR). Lack of 
energy affects the function of the Na^K* pump which is located at the cell 
membrane. Na*K+ pump via active transport of ions maintains higher 
intracellular concentration of potassium and lower concentration of sodium. 
The ceil membrane becomes highly permeable leading to influx of Na+ and 
Ca2+ into the cell and efflux of K+ producing intracellular oedema.
2.3.1.1 Oedema: High-energy phosphates are vital for most cellular 
functions: from maintaining homeostasis, signal integration transduction, cell 
proliferation and differentiation to execution of the apoptotic death cycle. 
Although membrane phosphatases act slowly during ischemia, ATP depletion 
inhibits Na+K+ membrane phosphatase, thereby impairing the ability to 
maintain membrane potential and cell excitability, which require protection 
from gradient-driven K+ and Na+ ion trafficking. Sodium enters the cytoplasm 
accompanied by large amounts of water, producing oedema, the degree of 
which is dependent on the extent and duration of ischemia.
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2.3.1.2 Calcium overload: Mitochondrial dysfunction is a critical event 
during ischemia, as it initiates both necrosis and apoptosis cascades during 
reperfusion. The organelle is both the site wherein ROS particles are 
produced and the preferred target of the injury. During ischemia, the 
Na+/Ca2+ antiporter stops pumping calcium out of the cell, since sodium 
accumulating within the cell cannot be removed by the ineffective Na/K- 
ATPases, leading the Na/Ca exchanger to start to work in the reverse 
direction. Influx of extracellular calcium occurs only during prolonged 
ischemia and reperfusion (Kusuoka, Camilion de Hurtado and Marban, 
1993).
Increased intracellular calcium activates calpain and causes translocation of 
Na/K ATP-hydrofase to the cytoplasm, increasing its deficit (Dunbar and 
Caplan, 2001). Mitochondrial permeability transition is a nonselective pore in 
the inner mitochondrial membrane, which is almost impermeable under 
physiological conditions, but opens due to a high mitochondrial content of 
calcium. Increased cytosolic calcium at neutral pH activates some 
cytoplasmic phospholipases and proteases. Two important groups of 
proteases that are activated in response to increased intracellular calcium 
are calpains (calcium-dependent cysteine proteases) and caspases. The 
former cleave a variety of proteins, including protein kinase C, fodrin, and 
cytoskeletal proteins while caspases have substrates within plasma 
membranes, lysosomes, mitochondria, and nucleus. Caspases are 
aspartate-specific cysteine proteases involved in the execution of apoptosis 
and cell death (Kosieradzki and Rowinski, 2008).
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Free radicals are formed even during global ischemia, when small amounts 
of oxygen are available. Deamination of adenosine provides a substrate for 
xanthine oxidase. The enzyme xanthine dehydrogenase changes its 
conformation in response to ischemia. It is believed to result in free radical 
formation as shown in Figure 2.1. However, a more important source of free 
radicals in ischemia is the respiratory complex III itself (Chen et al, 2007).
Figure 2.1: Potential intracellular pathways of ROS generation SOD, 
superoxide dismutase; DMSO dimethyl sulfoxide; DMTU, dimethyl thiourea; 
7U,thiourea; NMA, N methyl-L-arginine (DeForge et al, 1993)
2.4 Reperfusion Injury:
Reperfusion injury follows the ischaemic phase which occurs within hours 
and days of the initial insult. This period is highlighted by repair and 
regeneration. At cellular level apoptosis, autophagy and necrosis all occur 
together. Influx of calcium is well known to occur during the ischaemic phase 
due to disruption of Na/K pump but the levels return to normal and cells are 
able to make a recovery. An increase of cytoplasmic calcium which does not 
return to normal may be seen in irreversible injury. (Lee and Allen, 1992).
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When the circulation is re-established oxygenated blood ushers a release of 
large amount of free radicles the source of which is likely from the respiratory 
chain. Mitochondria are the key players and regulators during this phase. The 
acidic environment during ischemia may be responsible for keeping the 
permeability pores closed but these open in reperfusion phase (Kim, Jin and 
Lemasters 2006). Free radicles cause direct damage to surrounding cell 
membranes by lipid peroxidation. Endothelial cells are important mediators of 
this injury which are well preserved during ischemic phase but during 
reperfusion they become oedematous. Reactive oxygen species (ROS) are 
known to stimulate production of key transcription factors, growth factors and 
releasing inflammatory mediators like lnterleukin-8 (IL-8; CXCL8), Monocyte 
chemoattractant protein-1 (MCP-1; CCL2), and regulated on normal T cell 
expressed and secreted (RANTES; CCL5) (Lakshminarayanan et al, 1997). 
These chemokines recruit polymorphs and lymphocytes leading to cellular 
injury (Larsen et al, 1989). The final pathway leads to apoptosis and cell 
necrosis ending in destruction of tubules and fibrosis as shown in figure 2.2.
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Figure 2.2: Schematic representation of leucocyte recruitment, 
endothelial cell activation, and generation of inflammatory and 
vasoactive mediators that perpetuate tissue injury after graft 
reperfusion ROS, reactive oxygen species; GSH, glutathione; TxA2, 
thromboxane A2; ET, endothelin; PGI2, prostacyclin; Dashed lines indicate 
inhibition (Perico et al, 2004).
The role of the complement system in IRI is long established. Increase in the 
production of complement components is regulated by pro-inflammatory 
cytokines: primarily IL-6, TNF-a and IFN-y. While the importance of the 
alternative activation pathway has been demonstrated, recent evidence from 
mice suggests an additional role of the lectin-binding pathway. Ischemia and 
subsequent reperfusion leads to renal mannose-binding lectin (MBL) 
depositions in the early reperfusion phase, followed by deposition of C3, C6 
and C9 in the later reperfusion phase. In the kidney, the deposition of MBL-A 
and MBL-C co-localized with C6, demonstrated that MBL is involved in 
complement activation. MBL-depositions in peritubular capillaries and tubular 
epithelial cells can also be observed early after transplantation of 
ischemically injured kidneys (de Vries et al, 2004).
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Among the primary sources of ROS in kidney IRI are activated neutrophils, 
xanthine oxidase mediated conversion of xanthine to hypoxanthine, the 
mitochondrial electron transport chain, microsomal oxidation, and arachidonic 
acid metabolism. One of the major controversies regarding ROS generated 
during IRI is the mechanism of their involvement in the injury process. 
Although their harmful effects on lipids, proteins, and DNA are more or less 
understood, the ability of ROS and antioxidants to directly affect cellular 
signalling and in that way control gene expression needs additional 
investigation.
2.4.1 Reactive oxygen species:
Free radicals are small, diffusible molecules that have an unpaired electron. 
They tend to be reactive and can participate in chain reactions in which a 
single free radical initiation event can be propagated to damage multiple 
molecules. Polyunsaturated fatty acids, which are abundant in cell 
membranes, are oxidatively damaged by free radical chain reactions when 
exposed to 02 in the presence of trace metal ions. This process is known as 
lipid peroxidation.
2.4.1.1 Mitochondrial ROS Generation
2.4.1.2 Superoxide {02~)
The superoxide anion is created from molecular oxygen by the addition of an 
electron. It is not highly reactive. It lacks the ability to penetrate lipid
39
membranes and is therefore enclosed in the compartment where it was 
produced. The formation of superoxide takes place spontaneously and 
mitochondrial respiration is the major source with 0.2% of oxygen consumed 
being normally converted into superoxide in a quiescent state (St-Pierre et al, 
2002).
Dismutation of superoxide, both spontaneous and catalyzed by the 
superoxide dismutases, provides a major source of hydrogen peroxide in 
cells (reaction 1)
Reaction 1
O.J H-O.J •+2H4^II2Oo+Oo
2.4.1.3 Hydrogen peroxide:
Hydrogen peroxide (H2O2) is not a free radical but is nonetheless highly 
important much because of its ability to penetrate biological membranes. It 
plays a radical forming role as an intermediate in the production of more 
reactive ROS molecules including HOCI (hypochlorous acid) by the action of 
myeloperoxidase, an enzyme present in the phagosomes of neutrophils.
The cytotoxicity of hydrogen peroxide primarily occurs through its ability to 
generate hydroxyl radical through metal-catalyzed reactions, such as the 
Fenton reaction (Reaction 2).
Reaction 2
II202+Fe2+ ->Fe3++-0II+ oh
An important function of H2O2 is carried out in its role as an intracellular 
signalling molecule. H2O2 once produced by the above mentioned 
mechanisms is removed by at least three antioxidant enzyme systems, 
namely catalases, glutathione peroxidases and peroxiredoxins.
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2.4.1.4 Hydroxyl radical:
Due to its strong reactivity with biomolecules, hydroxyl radical (*01-1) is 
probably capable of doing more damage to biological systems than any other 
ROS. The Haber-Weiss reaction generates *0H from H2O2 and superoxide 
(O2 ). The reaction is very slow, but is catalyzed by iron. The first step of the 
catalytic cycle involves reduction of ferric ion to ferrous:
Fe3+ + -Os- -* Fe2+ + 02
The second step is the Fenton reaction:
Fe2+ + H2O2 -» Fe3+ + OH" + -OH 
Net reaction:
•O2 + H2O2 —> -OH + HO" + O2
2.4.1.5 Nitric oxide:
Nitric oxide (NO) represents an odd member of the free radical family and is 
similar to 02" in several aspects in that it does not readily react with most 
biomoiecules despite its unpaired electron. On the other hand it easily reacts 
with other free radicals (e.g. peroxyl and alkyl radicals), generating mainly 
less reactive molecules. 02~ in parallel with NO react with each other to give 
OONO" (peroxynitrite), which is highly cytotoxic (Beckman and Koppenol, 
1996).
Peroxynitrite (or its protonated form ONOOH) is a strong oxidizing agent and 
can lead to depletion of thiol groups, damage to DNA, and nitration of 
proteins.
OJ '-FNO—rONOO-
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In physiological concentrations NO functions mainly as an intracellular 
messenger stimulating guanylate cyclase and protein kinases, thereby 
relaxing smooth muscle in blood vessels.
The major intracellular reactive oxygen species and their metabolism are 
shown in Table 2.1.
Table 2.1: Major intracellular ROS molecules and their metabolism
(Nordberg and Arner, 2001)
ROS molecule Main sources Bnzymatic defense systems Product (s)
Superoxide (Oj-) 'leakage' of elections Superoxidc dismutase H2O2 + O;
from the electron transport (SOD)
chain
Superoxide reductase (in 
some bacteria)
H?0;
Activated phagocytes 
Xanthine oxidase
Flavoenzymes
Hydiogpn peroxide (H-O?) From Of" via superoxide Glutathione peroxidase H20 + GSSG
dismut ase (SOD)
Catalases H;0+ O2
NADPH-oxidase
(neutrophils)
Glucose oxidase
Xanthine oxidase
Peroxiredoxins (Prx) h2o
Hydroxyl radical (*OH) From OJ" and HjOj via 
transition metals (Fe or Cu)
Nitric oxide (NO) Nitric oxide synthases Glutathione/TrxR GSNO
2.4.1.6: Hydrogen peroxide and NF-kB:
Nuclear factor kappa-light-chain enhancer of activated B cells (NF-Kb) is a 
protein complex that controls the transcription of DNA. It is found in almost all 
animal cell types and is involved in cellular responses to stimuli such as 
stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and 
bacterial or viral antigens (Brasier, 2006), (Gilmore, 2006).
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NF-kB belongs to the category of "rapid-acting" primary transcription factors. 
Transcription factors that are present in cells in an inactive state and do not 
require new protein synthesis to be activated. This allows NF-kB to be a first 
responder to harmful cellular stimuli.
IkBo (nuclear factor of kappa light polypeptide gene enhancer in B-cells 
inhibitor, alpha) is a cellular protein that functions to inhibit the NF-kB 
transcription factor. IkBo inhibits NF-kB by masking the nuclear localization 
signals of NF-kB proteins and keeping them sequestered in an inactive state 
in the cytoplasm (Jacobs and Harrison, 1998). In addition, IkBq blocks the 
ability of NF-kB transcription factors to bind to DNA, which is required for NF- 
kB's proper functioning (Verma et al, 1995).
IkB kinase (IKK) enzyme complex is part of the upstream NF-kB signal 
transduction cascade. IKK specifically, phosphorylates the inhibitory IkBo 
protein. This phosphorylation results in the dissociation of IkBo from NF-kB 
and thereby activates NF-kB (Karin, 1999).
NF-kB is located in the cytosol complexed with the inhibitory protein IkBo. 
Through the intermediacy of integral membrane receptors, a variety of 
extracellular signals can activate the enzyme IKK. The activated NF-kB is 
then translocated into the nucleus where it binds to specific sequences of 
DNA. The DNA/NF-kB complex then recruits other proteins such as 
coactivators and RNA polymerase, which transcribe downstream DNA into 
mRNA, which, in turn, is translated into protein, which results in a change of 
cell function (Perkins, 2007).
H2O2 concentrations required to activate NF-kB are typically in the range 0.1 
to 1 mM, which is much higher than the 5-15 pM range observed during
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inflammation. Higher levels of oxidative exposure can turn a potential positive 
stimulus by H2O2 into an inhibitory effect (Test and Weiss, 1984), (Liu and 
Zweier, 2001).
In 1991, Schreck et al were the first to demonstrate that direct addition of 
H2O2 to the culture medium of a subclone of Jurkat cells could activate NF- 
kB (Schreck, Rieberand Baeuerle, 1991).
NF-kB activation by H2O2 is highly cell-type specific and involves quite 
different mechanisms (Li and Karin, 1999). In T cells, H2O2 induces a Syk- 
mediated tyr 42 or an IKK-induced ser 32 and 36 phosphorylation of IkBo, 
depending on the expression of the inositol phosphatase SHIP-1. In epithelial 
cells, H2O2 triggers IKK complex activation through protein kinase D 
activation as shown in Figure 2.3.
Figure 2.3: Mechanisms of H202-induced NF-kB activation in T cells and 
epithelial cells (Gloire, Legrand-Poels and Piette 2006)
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NF-kB activation by Interleukin 1 receptor, type I (IL-1R1) depends on 
receptor endocytosis and endosomal ROS formation. IL-1p stimulation 
induces MyD88-dependent endocytosis of IL-1R1, an event required for NF- 
kB activation through Nox2-dependent H2O2 production as shown in Figure 
2.4 (Gloire, Legrand-Poels and Piette, 2006).
a
Figure 2.4: NF-kB activation by Interleukin 1 receptor, type I (IL-1R1)
(Gloire, Legrand-Poels and Piette, 2006)
2.5 Antioxidants
Numerous antioxidant strategies exist and can be used to protect against 
ROS toxicity. The cellular antioxidant systems can be divided into two major 
groups, enzymatic and nonenzymatic. Major antioxidant enzyme systems 
are: superoxide dismutase, catalase, glutathione peroxidase (GPx), 
additional antioxidant enzymes such as peroxiredoxin, glutaredoxin (Grx),
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and thioredoxin reductase (TrxR) also contribute to cellular protection against 
oxidation.
Manganese containing SOD (MnSOD) is localized in the mitochondria; 
copper and zinc containing SOD (CuZnSOD) is located in the cytoplasm and 
the nucleus; and extracellular SOD (ECSOD) is expressed extracellularly in 
some tissues. Other compartmentalized antioxidant enzymes include 
catalase, which is found in peroxisomes and the cytoplasm, and GPx, which 
can be found in many subcellular compartments including the mitochondria 
and the nucleus depending on the family member (Weydert and Cullen, 
2010).
Intracellular enzymatic antioxidants are superoxide dismutase (SOD), 
catalase and GPx that convert potential substrates (superoxide anion 
radicals and hydrogen peroxide) to less reactive forms in the body (Halliwell 
and Gutteridge, 1995), (Rice-Evans and Burden, 1993).
The major nonenzymatic antioxidant molecules are glutathione and vitamins 
A, C, and E (Finkel and Holbrook, 2000).
2.5.1 Superoxide dismutases (SOD)
Superoxide dismutases were the first genuine ROS-metabolizing enzymes 
discovered (McCord and Fridovich, 1969). They form the first line of defence 
against superoxide radicals as two isoenzymes exist, 80-kDa MnSOD 
present in mitochondria, and the cytosolic 32-kDa Cu/ZnSOD. In the reaction 
catalyzed by SOD, two molecules of superoxide form hydrogen peroxide and 
molecular oxygen and are thereby a source of cellular hydrogen peroxide. 
202* +2H+—►HsOa+Os
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The reaction catalyzed by SOD is extremely efficient, limited in essence only 
by diffusion. In mitochondria, superoxide is formed in relatively high 
concentrations due to the leakage of electrons from the respiratory chain. 
MnSOD is essential or near essential to life since no inherited diseases have 
been found in which MnSOD is deficient, and knockout mice lacking MnSOD 
die soon after birth or suffer severe neurodegeneration (Melov et al, 1998). 
Expression of MnSOD is, in contrast to CuZnSOD, induced by oxidative 
stress and, interestingly and also by Thioredoxin (Das, Lewis-Molock and 
White, 1997).
Cytosolic CuZnSOD seems less important than MnSOD, and transgenic 
animals lacking this enzyme are able to adapt so that the phenotype appears 
normal (Ohlemiller et al, 1999).
2.5.2 Catalases
Catalases are mainly heme-containing enzymes. They are localised in 
mammalian cells in peroxisomes, where they catalyze the dismutation of 
hydrogen peroxide to water and molecular oxygen:
2 H2O2—>02+21^0
Another antioxidative role of catalase is to lower the risk of hydroxyl radical 
formation from H2O2 via the Fenton-reaction catalyzed by Copper or Iron ions 
(Halliwell, 1999).
Catalase binds to NADPH, which protects the enzyme from inactivation and 
increases its efficiency (Kirkman et al, 1999). Catalase activity assays 
typically involve the addition of its substrate (i.e H2O2), and the degradation of 
H2O2 is followed spectrophotometrically.
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2.5.3 Glutathione peroxidases (GPx)
There are at least five different GPx in mammals (GPx1-5), all of which 
contain selenocysteine. GPx1 and GPx4 (or phospholipid hydroperoxide 
GPx) are both cytosolic enzymes abundant in most tissues (de Haan et al, 
1998). GPx2 (gastrointestinal GPx) and GPx3 (plasma GPx) are mainly 
expressed in the gastrointestinal tract and kidney, respectively (de Haan et 
al, 1998), (Dreher et al, 1997). GPx3 may be catalytically regenerated by the 
Trx system (Bjornstedt et al, 1994). All glutathione peroxidases catalyze the 
reduction of H2O2 using glutathione as substrate. 
R00H+2GSH^R0H+GSSG+H20
The catalytic mechanism proposed for reduction of hydroperoxides by GPx 
involves oxidation of the active site selenolate (Se“) to selenenic acid (SeOH) 
(Epp, Ladenstein and Wendel, 1983).
Decreased GPx-1 activity can promote susceptibility to oxidative stress by 
allowing for the accumulation of harmful oxidants, whereas excess GPx-1 
may promote reductive stress, characterized by a lack of essential ROS 
needed for cellular signalling processes. Excess oxidants or loss of essential 
ROS can each lead to diminished cell growth and promote apoptotic 
pathways (Lubos, Loscalzo and Handy, 2011).
2.5.4 Accessory antioxidant enzymes
Among these, the Thioredoxin (Trx), Glutaredoxin, and Peroxiredoxin 
systems are important contributors.
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2.5.4.1 Thioredoxin system:
The thioredoxin system consists of the two antioxidant oxidoreductase 
enzymes Thioredoxin (Trx) and Thioredoxin reductase (TrxR). TrxR 
catalyzes the reduction of the active site disulphide in Trx using nicotinamide 
adenine dinucleotide phosphate (NADPH), Reduced Trx is a general protein 
disulfide reductant. Both TrxR and Trx have antioxidant properties (Nordberg 
and Arner, 2001).
TrxR reduces the active site disulphide in thioredoxin and several other 
substrates directly under consumption of NADPH. Reduced thioredoxin is 
highly efficient in reducing disulphides in proteins and peptides, including 
peroxiredoxins and glutathione disulphide as shown in Figure 2.5.
g, MAnDU > U+ TV^ C
Figure 2.5: Enzymatic reactions of the thioredoxin system
Three distinct variants of human Trx have been characterized. The classical 
12-kDa thioredoxin Trx-1, is known to be a multifunctional protein that can 
exist in the extracellular environment, cytoplasm and the nucleus (Arai et al, 
2006). In the cytoplasm, Trx has been shown to regulate the redox 
environment of the cell and also the activity of certain proteins such as the 
apoptosis signal-regulating kinase-1 (Saitoh et al, 1998).
Trx-2 is located in mitochondria, mitochondrial Trx-2 is a 166 amino acid, 18 
kDa protein with a conserved Trx catalytic site (Powis and Montfort, 2001).
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Trx-2 has been shown to be critical in the regulation of mitochondrial 
membrane potential, NF-kB activation and apoptosis (Hansen, Zhang and 
Jones, 2006). Trx-2 seems to outweigh all the other mitochondrial defences 
in importance (Maulik and Das, 2008).
The third thioredoxin SpTrx, is a Trx expressed in spermatozoa (Miranda- 
Vizuete et al, 2001).
Trx modulates the signal transduction properties of ROS by reducing the 
intracellular disulphides induced by ROS and by lowering the levels of ROS 
directly. In the case of transcription factors, Trx enhance activator 
protein1(AP-1) activation. NF-kB activation, on the other hand, is clearly 
inhibited by reduced Trx in the cytosol (Kondo et al, 2006). Beneficial effects 
of thioredoxin, however may be a result of their capacity to act as a signalling 
molecule and not primarily as a radical scavenger. Recently, it was found that 
a combination of A/-acetyl cysteine and thioredoxin might be far more 
effective than the administration of thioredoxin alone (Isowa et al, 2000).
2.5.4.2 Thioredoxin reductase:
Thioredoxin reductase (TrxR) contains selenium in the form of 
selenocysteine that catalyzes the NADPH-dependent reduction of 
thioredoxin, which is the major protein disulphide reductase in cells. They are 
involved in reduction of hydrogen peroxide and also regeneration of 
glutathione peroxidase (Matsui et al, 1996).
The molecular weight is 55kDa and in mammals, three isozymes of TrxRs 
have been identified: a cytosolic one (TrxR1) a mitochondrial one (TrxR2)
50
and a third isozyme highly expressed in testes, thioredoxin glutathione 
reductase (Bindoli et al, 2009).
Similar to TRX, glutaredoxin (GRX) is a thiodisulphide oxidoreductase that is 
involved in the protection and repair of protein and non-protein thiols during 
periods of oxidative stress (Berndt, Lillig, and Holmgren, 2007).
2.5A3 Glutathione:
Glutathione (GSH) is the most abundant intracellular thiol-based antioxidant, 
present in millimolar concentrations in all living aerobic cells. Its function is 
mainly as a sulphydryl buffer, but GSH also serves to detoxify compounds 
either via conjugation reactions catalyzed by glutathione S-transferases or 
directly. Oxidized glutathione is reduced by the NADPH-dependent 
flavoenzyme glutathione reductase. Oxidized glutathione may also be 
efficiently reduced by thioredoxins of E. coli, Plasmodium falciparum, and 
human origin. Hydrogen peroxide is reduced by glutathione peroxidases by 
oxidation of two molecules of glutathione forming glutathione disulphide that 
subsequently can be reduced by glutathione reductase under consumption of 
NADPH. Glutathione also reduces glutaredoxins (Grx) that in their turn 
reduce various substrates. Specific for glutaredoxins is the reduction of 
glutathione mixed disulphides such as glutathionylated proteins. Glutathione 
S-transferases catalyze the conjugation of glutathione with other molecules, 
thereby functioning as an intermediate step in the detoxification of 
miscellaneous toxic substances as shown in figure 2.6.
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NADPH + , GSSG Gncrwi ReducIfiQ equivalents to:
* Protein
* GSU-mlxed dlsu'fides
* Iwi Mw-conipoufids2 GSH
> GS’Conjugate + H
substrate
Figure 2.6: Schematic summary of the major glutathione-associated 
antioxidant systems (Nordberg and Arner, 2001).
Several extracellular antioxidants such as proteins (transferrin, lactoferrin, 
albumin, cerruloplasmin) and urate prevent free radical reaction in the body 
sequestering transition metal ions by chelation in plasma. Albumin, bilirubin 
and urate may also scavenge free radicals directly. Furthermore, plasma has 
a considerable peroxyl radical scavenging ability, which is mainly determined 
by its content of ascorbic acid (Gutteridge, 1995), (Rice-Evans and Burdon, 
1993), (Frei, England and Ames, 1989).
Some antioxidants are located both intra- and extra-cellularly, such as a- 
tocopherol, which is the major lipid-soluble antioxidant, present in cellular 
membranes and in plasma lipoproteins. It is an effective chain-breaking 
antioxidant that protects polyunsaturated lipids from peroxidation by 
scavenging peroxyl radicals (Flalliweli, 1999).
2.5.4 N-acetyl cysteine:
Acetylcysteine (NAG) is the A/-acetyl derivative of the amino acid L-cysteine, 
and is a precursor in the formation of the antioxidant glutathione in the body. 
The thiol (sulphydryl) group confers antioxidant effects and is able to reduce 
free radicals shown in figure 2.7.
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Figure 2.7: Chemical structure of N-acetyi cysteine
NAC is used clinically as a mucolytic drug and also in paracetamol over 
dosage. It has also been shown to prevent contrast induced nephropathy 
(Tepel et al, 2000). NAC is known as a drug that easily enters the cell and 
because of its -SH group, it is able not only to scavenge ROS, such as 
hydrogen peroxide and the hydroxyl radical, but it can also easily be 
deacetylated to cysteine, an important precursor of cellular glutathione 
synthesis. Therefore NAC scavenges oxidants both directly and indirectly. 
NAC has been tested in various laboratory models for its anti-oxidant 
properties. Ayvaz et al found that NAC administration caused an 
improvement in the histopathological findings of ischemia /reperfusion 
damages (Ayvaz et al, 2009). Fuller at al showed that donor pre-treatment in 
rats with NAC preserved renal metabolism and may improve outcomes of l/R 
injured kidney transplants (Fuller et al, 2004). Several rat models of IRI have 
also shown benefits of NAC (Di Giorno et al, 2006), (Sehirli et al, 2003).
NAC has also been shown to attenuate IRI in lung transplantation model (Inci 
et al, 2007) and to preserve myocardial function in acute myocardial 
infarction (Arstall et al, 1995). Other studies have also shown its role in 
inhibiting production of chemokines. Lappas et al (Lappas, Permezel and 
Rice, 2003) have shown that preincubation with NAC could suppress NFkB
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activity and production of chemokines like IL-8. Wuyts have shown that N- 
acetylcysteine inhibits interleukin-17-induced interleukin-8 production from 
human airway smooth muscle cells (Wuyts et al, 2004).
2.6 Use of proximal tubular cells in cell culture:
There are many limitations in using in vivo models of renal IRI to elucidate 
the detailed signalling cascades. In vivo approaches must deal with multiple 
cell types within an organ and also with complex physiological control within 
an animal. In vitro studies with a pure population of a single cell type 
eliminate these complex external physiological influences and allow the direct 
study of signalling cascades. The proximal tubules (especially, the straight, 
distal portion or S3 segment) located in the outer medulla of the kidney are 
the primary site of injury in renal ischemia and reperfusion (Lieberthal and 
Nigam, 1998). This region is marginally oxygenated under normal 
physiological conditions, with a high basal metabolic demand. Therefore, with 
hypoxic or ischemic insult, proximal tubules in the outer medullary zone 
suffer the most damage.
Studies assessing mechanisms of proximal tubular cell physiology and 
pathophysiology increasingly utilize cell culture systems to avoid the 
complexity of whole organ/whole animal experiments. In vitro cell systems 
have proven very valuable in defining cell function and dysfunction in a 
variety of normal and disease states. In vitro cultures enable investigators to 
focus directly on the epithelium itself, removed from haemodynamic, neural, 
and hormonal factors that complicate studies of epithelia in vivo. A few 
investigators have reported the growth of human renal proximal tubular cell 
cultures in primary culture or early passage (Vesey et al, 2009).
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However, ongoing harvesting of these cells is tedious and cell numbers from 
any given isolate are limited. Moreover, many investigators interested in 
human disease have no access to fresh human kidney tissue suitable for 
harvesting for in vitro studies (Racusen et al, 1997).
Research on IRI is often performed in animal models. Such in vivo methods 
may carry high risk of discomfort to the animal. Although animal models 
mimic physiological changes more closely, a cell culture model has several 
advantages:
• The cell population is well defined.
• The cells can be observed directly under a microscope.
• The physiological function of these cells is well maintained.
• There is easy access for biochemical (secretion, staining) analysis.
• The ceils can also be stored and maintained for long periods.
Cell culture methods have been used in the past to study ischemia and 
reperfusion injury. Martou et al have used skeletal muscle cells (Martou et al, 
2006), while Lee et al have used endothelial cells to simulate ischemia- 
reperfusion injury (Lee et al, 2009). Du et al have used human proximal 
tubular cells (HK-2) for a hypoxia / reoxygenation model of injury (Du et al, 
2005). Daly et al have also used HK-2 cells to study effects of hypoxic pre­
conditioning (Daly et al, 2009).
2.6.1 HK-2 cells:
Ryan et al described the first use of HK-2 cells for cell culture. Primary 
proximal tubular cell culture from normal adult human renal cortex exposed to 
a recombinant retrovirus containing the HPV 16 E6/E7 genes, resulted in a
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cell line designated HK-2 (human kidney-2) which has grown continuously in 
serum free media for more than one year (Ryan et al, 1994).
HK-2 cell growth is epidermal growth factor dependent and the cells retain a 
phenotype indicative of well-differentiated proximal tubular cells (positive for 
alkaline phosphatase, gamma glutamyl transpeptidase, leucine 
aminopeptidase, acid phosphatase, cytokeratin, integrin, and fibronectin. 
Furthermore, HK-2 cells retain functional characteristics of proximal tubular 
epithelium (Na dependent I- phlorizin sensitive sugar transport; adenylate 
cyclase responsiveness to parathyroid hormone.
However, these changes do not equate with malignant transformation since 
the host cells retain features of differentiation, and thus, their growth is 
anchorage dependent and they remain under the control of many normal 
regulatory processes. Therefore, this type of cell preparation may represent a 
useful compromise between primary cultures and highly transformed cell 
lines. Many regulatory processes remain intact, and yet the need for 
repeated PTC isolation and characterization is eliminated (Ryan et al, 1994), 
(Racusen et al, 1997).
2.6.2 HK-2 Cells and Transport:
HK-2 cells have been used in transport studies of riboflavin (Kumar et al, 
1998) and to study the function of the P-glycoprotein pump, multidrug 
resistance protein 1, which is expressed in the basolateral basement 
membrane of HK-2 cells (Romiti, Tramonti and Chieli, 2002).
Studies of extracellular glutathione peroxidase have demonstrated 
polarization of HK-2 cells on permeable membranes. Extracellular glutathione 
peroxidase is secreted through the basolateral membrane of human kidney
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proximal tubule cells into the extracellular fluid of the kidney, and from there 
enters blood plasma (Whitin et al, 2002).
2.7 Use of Hydrogen peroxide in cell culture:
Hydrogen peroxide has several advantages over superoxide as a cellular 
messenger. First, due to its uncharged nature it can diffuse more easily 
through membranes than can the superoxide anion. This might facilitate its 
removal by catalase within peroxisomes or by diffusion out of the cell. 
Hydrogen peroxide may also serve as a hormone-like extracellular stimulus; 
it is produced at sites of inflammation by neutrophils and macrophages, and 
could thus activate nearby ceils. The second advantage may be its lower 
reactivity and toxicity.
Unlike superoxide, hydrogen peroxide is not a free radical. This increases its 
diffusion radius within the cytoplasm before decay. Finally, hydrogen 
peroxide can be completely detoxified in a single enzymatic step into H2O 
and O2 whereas superoxide is predominantly degraded via H202, and 
therefore causes prolonged toxicity.
Hydrogen peroxide is commonly used to study oxidative stress in proximal 
renal tubules (Andreucci et al, 2009), (Lee, Lee and Han, 2006), (Sheridan et 
al, 1996), (Van et al, 2009).
2.8 Chemokines:
Chemokines are a family of chemotactic cytokines that were first identified on 
the basis of their ability to induce the migration of different cell types, 
particularly those of lymphoid origin. A wealth of data has demonstrated that 
chemokines working in concert with selectins and integrins act as directional 
signals to sort and direct effector leukocyte migration (Simonet et al, 1994),
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(Baggiolini, Walz and Kunkel, 1989). In addition, chemokines have also been 
shown to activate leukocytes, influence haematopoiesis, and modulate 
angiogenesis (Li et al, 2005), (Singh et al, 2011). However, chemokines and 
their receptors are also important in dendritic cell maturation, B, and T cell 
development, Th1 and Th2 responses, infections, tumour growth as well as 
metastasis (Rossi and Zlotnik, 2000).
Like other cytokines, chemokines are secreted, and function locally in either 
paracrine or autocrine fashion. Furuichi and Daemen have shown chemokine 
involvement in mediating ischemic renal injury (Furuichi et al, 2008), 
(Daemen et al, 2001).
2.8.1 Members:
More than 50 human chemokines and 20 chemokine receptors have been 
described to date, with additional candidates currently under investigation 
(Ruffini et al, 2007). Chemokines can be classified into four subfamilies on 
the basis of the number and location of the cysteine residues at the N- 
terminus of the molecule and are named CXC, CC, CX3C, and C, in 
agreement with the systematic nomenclature (Rollins, 1997).
2.8.2 Regulation of Chemokine Expression
Chemokines are regulated at transcriptional, post transcriptional, 
translational, and posttranslational levels (Holtmann et al, 1999). Many, but 
not all, of the proinflammatory chemokines are induced by IL-ip or tumour 
necrosis factor-a (TNF-a), RANTES and MCP-1 are upregulated in the 
presence of IL-2 (Loetscher et al, 1996), (Muselet-Charlier et al, 2007).
Some of the best studied pro-inflammatory chemokines (IL-8, RANTES, 
MCP-1) are controlled at the transcriptional level by the transcription factors
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NF-kB, CAAT enhancer binding protein, and activator protein-1 (Hoffmann et 
al, 2002). Their activation requires a complex cascade of steps including 
phosphorylation by multiple kinases and phosphatases, degradation of 
transcriptional inhibitors, translocation of transcription factors from cytoplasm 
to nucleus. These signalling pathways can be different for each stimulus and 
transcription factor and are further complicated by “cross-talk” between the 
various pathways (Mukaida et al, 1994), (Oliveira et al, 1994).
Although at first glance this may appear to be an unnecessarily complicated 
system, it allows the fine-tuning and integration of the multiple signals 
required for a complex signal and tissue-specific biological response. These 
biochemical events are potential targets for therapeutic intervention. For 
example, glucocorticoids interfere with NF-kB activation (Bladh et al, 2005). 
Similarly, agents that influence cAMP levels often modulate the stimulatory 
signals for chemokine expression (Banerjee et al, 2011). The inhibition of 
chemokine expression seen after treatment with free radical scavengers may 
be due to interference with NF-kB activation, but may also involve other 
redox related steps (Haddad, 2002).
2.8.3 Principles of chemokine action:
Chemokines are produced by intrinsic cells as well as by infiltrating cells. 
They are released by stimulated cells and act locally. They act through G 
protein-coupled with transmembrane receptors and induce calcium influx. 
Chemokine receptor expression is cell-specific. They induce haptotaxis (ceil 
migration along surface gradients) and also can activate adhesion molecules. 
Chemokines bind to proteoglycans and extracellular matrix, particularly on 
luminal surface of endothelial cells to attract leucocytes from blood into the
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tissues. Activated cells have an increased production of ROS causing oxygen 
burst and the release of granules and proteinases by leukocytes. They can 
have a wide variety of actions and control aspects of immunomodulation, 
angiogenesis, hematopoiesis, and development as shown in figure 2.8.
The chemokine field has also received considerable attention since 
chemokine receptors were found to act as co-receptors for HIV infection 
(Alkhatib et al, 1996). In addition, chemokines, along with adhesion 
molecules, are crucial during inflammatory responses for a timely recruitment 
of specific leukocyte subpopulations to sites of tissue damage. Chemokines 
and their receptors are also important in dendritic cell maturation, B and T 
cell development, Th1 and Th2 responses, infections, angiogenesis, and 
tumour growth as well as metastasis (Vicari et al, 1997), (Strieter et al, 1995).
wound healing Th1/Th2 development
lymphoid trafficking
CHEMOKINES
angiogenesia/ang ioatasis
lymphoid organ 
development
inflammation
metastasis
cell recruitment
Figure 2.8: Biological functions of chemokines and chemokine 
receptors. (Rossi and Zlotnik, 2000)
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Advances in understanding of chemokine receptor biology have highlighted 
that a controlled regulation of their activity is probably more important than 
their activation per se, certainly in the context of the immune system for both 
homeostasis and inflammatory responses. Individual receptors are subject to 
different mechanisms of regulation depending upon the type of cells on which 
they are expressed, the cell differentiation and activation status, as well as 
the microenvironment. Molecular mechanisms involved in the regulation are 
shared among chemokine receptors while others are purely receptor-specific, 
with either transient or permanent consequences on cell responsiveness to 
chemokine stimulation. The complexity of the regulation process confers 
specificity to what is an apparently redundant chemokine/chemokine receptor 
system (Bennett, Fox and Signoret, 2011).
2.8.4 1L-8:
lnterleukin-8 (IL-8) represents a classical CXC chemokine and is a potent 
inducer of neutrophil chemotaxis (Yoshimura et al, 1987). It is produced early 
in inflammation as a direct result of interaction of cells with such stimuli as 
endotoxin, and it will also be further up-regulated by the early, alarm 
cytokines such as TNFa and IL-1. Reactive oxygen species, reactive nitrogen 
intermediates (RNI), and tissue injury are also frequent companions at sites 
of acute inflammation. The accepted hypothesis that links these observations 
may be stated as follows: PMN’s are recruited to sites of acute inflammation; 
once at the site, they produce substantial quantities of ROS, which, together 
with released proteases injure the tissue. However, ROS/RNI may serve a 
completely different function in acute inflammation, where they do not
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operate solely as end-stage effector molecules, but also as mediators 
regulating cytokine gene expression.
ROS have in fact been shown to be important inducers of both prokaryotic 
and eukaryotic gene expression by activation of various transcription factors 
including NF-kB (Ali and Sultana, 2011). The predicted sequence is as 
follows: low intracellular concentrations of ROS and RNI serve to up-regulate 
expression of IL-8, which then induces neutrophil chemotaxis. This 
hypothesis does not in any way contradict previous work concerning ROS / 
RNI and tissue damage, it merely expands their inflammatory role as 
initiators of the cascade that elicits neutrophils.
In contrast to other classic neutrophil chemoattractants such as ieukotriene 
B4, C5, platelet activating factor, and the bacterial peptide f-MLP, IL-8 
(CXCL8) is an extremely stable protein that is resistant to proteolysis and 
denaturation and has a prolonged biological activity in vivo. The stability of 
the IL-8 (CXCL8) protein and the sustained expression of its m-RNA suggest 
that the overall biological impact of IL-8 (CXCL8) may be greater than that of 
other neutrophil chemoattractants. Furthermore, since IL-8 (CXCL8) is 
produced de-novo in the presence of an inflammatory stimulus and not from 
pre-existing or latent factors, modulation of IL-8 (CXCL8) production may 
provide a more promising pharmacological target than other 
chemoattractants.
2.8.5 MCP-1
The monocyte chemoattractant protein-1 (MCP-1/CCL2) is a member of the 
C-C chemokine family, and a potent chemotactic factor for monocytes.
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Human MCP-1 is composed of 76 amino acids and is 13 kDa in size (Van 
Coillie, Van Damme and Opdenakker, 1999).
MCP belongs to a family composed of at least four members (MCP-1, -2, -3, 
and -4). CCL2 is produced by a variety of cell types, either constitutively or 
after induction by oxidative stress, cytokines, or growth factors and is one of 
the key chemokines that regulate migration and infiltration of 
monocytes/macrophages (Deshmane et al, 2009).
A biphasic expression of MCP-1 (CCL2) and other chemokines, coinciding 
with the acute inflammatory and the later reparative phase, in renal ischemia 
reperfusion injury was observed by Stroo et ai (Stroo et al, 2010).
Takaya et al have shown that in proximal tubules cells albumin was found to 
induce the transcription and translation of MCP-1 (CCL2) (Takaya et al, 
2003).
2.8.6 RANTES
RANTES (for ‘regulated upon activation normal T cell expressed and 
secreted’) is a small protein of 68 amino acids which is also known as CCL5 
(Zlotnik and Yoshie, 2000). The chemotactic activity of RANTES brings T 
cells, dendritic cells, eosinophils, NK cells, mast cells and basophils to sites 
of inflammation and infection. Whereas this cytokine was initially considered a 
T cell-specific protein, it has since been found to be produced by many cells 
in the body including platelets, macrophages, eosinophils, and fibroblasts, as 
well as endothelial, epithelial, and endometrial cells (Appay and Rowland- 
Jones, 2001).
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2.9 AIMS OF THE STUDY:
The data from experimental animals and cell cultures have indicated that the 
formation of ROS and consequent oxidative stress play an important role in 
the pathogenesis of ischemia reperfusion injury. Not only do they cause 
direct cellular damage but they also induce chemokines like IL-8 (CXCL8) 
and MCP-1 (CCL2) which recruit neutrophils and monocyte respectively. This 
leads to an inflammatory state causing further damage to the affected organ. 
Antioxidant enzymes form the primary defence system against the ROS 
during reperfusion injury and this study was designed to evaluate the 
expression of different oxidant and antioxidant mechanisms in renal ischemia 
reperfusion injury.
The specific aims of the study were:
1. To measure antioxidant enzyme response in immortalised human 
proximal renal tubular cells after stimulation with hydrogenperoxide, a 
simulated pathological condition of ischemia reperfusion injury.
2. To determine the ability of proximal human tubular cells to produce 
chemokines like IL-8, MCP-1 and RANTES after hydrogenperoxide 
stimulation.
3. To determine if antioxidant like acetyl cysteine can suppress this 
stimulation.
4. To measure oxidative stress markers in kidney biopsies from renal 
transplant recipients and identify the role of oxidative stress in various 
pathological conditions and link it with the labarotary model.
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CHAPTER 2
MATERIAL AND METHODS
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3. METHODS
(A) Laboratory:
Measurement of markers of oxidative stress and adaptive responses in 
response to simulated pathological condition of ischemia reperfusion injury 
and to measure the induction of pro-inflammatory chemokines IL-8(CXCL8), 
MCP-1(CCL2) and RANTES(CCL5).
(B) Clinical:
Measurement of markers of oxidative stress from renal transplant recipients 
with IRI, acute cellular rejection (ACR) and chronic allograft nephropathy 
(CAN) from renal biopsy samples.
This project will attempt to link novel mechanisms of injury in cell culture 
experiments and oxidative stress responses in a clinical setting that occur 
during ischemia reperfusion injury, acute cellular rejection and chronic 
allograft nephropathy.
3.1 LABORATORY STUDIES
3.1.1 Materials:
HK-2 human kidney, proximal tubule cells, transformed, American Type
Culture Collection (ATCC, CRL-2190) Rockville, MD
Keratinocyte Serum Free Media (KSFM, Invitrogen Lifetechnologies, 17005-
042)
Fetal Bovine Serum, 100 ml, heat inactivated (Invitrogen Life technologies, 
10082139)
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Trypsin-EDTA (0.25% Trypsin, 1mM EDTA.4Na) (Invitrogen Life 
technologies, 25200)
Glutamine 
HEPES buffer 
Epidermal Growth Factor
Human CCL2/MCP-1 Immunoassay (Quantikine) DCPOO, R&D Systems 
Human CXCL8/IL-8 Immunoassay (Quantikine) DY208, R&D Systems 
Interleukin 1 beta (IL-1p) Human recombinant: T9401 (Sigma)
N- Acetyl cysteine: A9165 (Sigma)
Hydrogen peroxide 30% w/w soln: H1009 (Sigma)
Corning Brand Culture Flasks, T25 (Fisher Scientific, 10-126-28)
Corning Brand Culture Flasks, T75 (Fisher Scientific, 10-126-37)
Falcon polystyrene 35 mm dishes (Fisher Scientific, 08-722A)
Wheaton Cryule Vial (Cryovials) (Fisher Scientific, 03-341-18N)
Nalgene Cryogenic Controlled-Rate Freezing Container (Fisher Scientific, 15- 
350-50)
3.1.2 Equipment:
IEC PR-7000M centrifuge, rotor 966, International Equipment Company 
Steril®GARD II Class II Type A/B3 Biosafety Cabinet, The Baker Company 
Nuaire US Autofiow CO2 water-jacketed incubator 
Zeiss Axiovert25 phase contrast microscope
3.1.3 Cell Culture Techniques:
Immortalized human proximal renal tubular epithelial HK-2 cells were 
obtained from ATCC. Cells were tested and shown to be negative for 
mycoplasma using the Hoechst 33258 (Bisebenzamide) DMA staining
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method (Sigma, Poole, UK). Cells were cultured until 90-95% confluent in 
six-well plates or T75 flasks in DMEM/Ham's F12 medium supplemented with 
5.5 mM glucose, 2 mM L-glutamine, 5 pg/ml insulin, 5 pg/ml transferrin, 5 
ng/ml sodium selenite, 0.4 pg/ml hydrocortisone, 5 ng/ml epidermal growth 
factor, 100 U/ml penicillin, 100 pg/ml streptomycin, 20 mM HEPES, and 10% 
PCS. These cells were used for no more than 10 passages. Media was 
changed on alternate days. All cells were grown in the appropriate growth 
media until they were about 80-90% confluent. HK-2 cells cultured with 
serum were growth arrested for 48h SFM. Cells cultured under serum free 
conditions were also given a 24h equilibration period after reaching the 
desired confluency,
3.1.3.1 Subculture and Feeding:
All conditions were under Biosafety Level 2 containment, performed in a 
Class II Biosafety Hood using sterile pipettes and plastic/glassware, wearing 
a laboratory coat and double-gloved. Subculture was performed weekly or 
when the monolayers reached 80% confluence as assessed by phase- 
contrast microscopy. Media from flask-grown cells were poured into a waste 
flask. The monolayers were rinsed with 1.5 ml/T25, 3 ml/T75 HEPES 
Buffered Saline Solution (HBSS) then trypsinized for 10 min to lift cells from 
flasks. Trypsinization was performed by adding 1.5ml /T25 or 3 ml/T75 0.25% 
trypsin, 0.05% EDTA (Invitrogen), decanting after 30 seconds and incubating 
the monolayer in the residual trypsin solution. When cells were released from 
the flasks (10 min), culture medium was added to each flask (5 ml/T25, 8 
ml/T75) and swirled over the cells. The cell suspension was transferred to a 
15 ml or 50 ml centrifuge tube and centrifuged at 270 x g for 5 min at 4°C
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(IEC PR-7000M centrifuge, rotor 966). The supernatant was discarded and 
the pellet resuspended in culture medium. Using a hemocytometer, the cell 
suspension was enumerated and the cells seeded into new flasks or plates. 
Cells grown in T75 flasks were seeded at a density of 4.0x105 cells in 25 ml 
or split at a one to four ratio and fed twice weekly. Cells grown in T25 flasks 
were seeded at a density of 1 to 1.5x106 cells in 12 ml or at a one to four 
ratio and were fed every other day. Millicell inserts were seeded at 4.0x105 
cells in 2.0 ml culture medium in the basolaterai compartment with 1.5 ml 
culture medium added to the apical compartment. Ceils were fed every other 
day. Transwells were seeded at 4.0x105 cells or superseeded at 1.41x106 
cells in 2.6 ml culture medium in the basolaterai compartment with 1.5 ml 
culture medium added to the apical compartment. Cells were fed every other 
day or daily. Cells were maintained in an incubator at 37°C and 5% C02.
3.1.3.2 Cryopreservation of Cell Line:
Cells from intermittent passages were cryopreserved in a solution of culture 
medium (DMEM), 20% FBS and 10% dimethyl sulphoxide (DMSO) at a cell 
suspension of 1-1.5 x 106 cells/ml. The cryosuspension was prepared as a 
double-strength cryomedium (0.35 ml culture medium, 0.10 ml FBS, 0.05 ml 
DMSO per vial) to which a cell suspension (0.5 ml x 2.0 to 3.0x105 cells/ml 
culture medium) was added dropwise to the cryovial for a final volume of 1ml 
cryosuspension. The cryovials were placed in a Nalgene cryofreezer 
temperature control unit and placed in a -20°C freezer overnight, transferred
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to a - 80°C freezer for 4 hours then placed in liquid nitrogen or in a -135°C 
freezer for long-term storage.
3.1.3.3 Cell Pellets for Assays:
Ceils grown in 35 mm plates, T25 or T75 flasks were rinsed X 2 with 1-3 ml 
HBSS, then scraped with a Teflon scraper, transferred into 15 ml or 50 ml 
centrifuge tubes and centrifuged at 270 x g for 5 min at 4°C (IEC PR-7000M 
centrifuge, rotor 966). Supernatant was discarded. Cells were stored at -80°C 
if not used immediately.
3.1.4 BIOCHEMICAL ANALYSIS
Cells were harvested in 550pl of PBS/well and sonicated for 10sec at 15 
microns (Soniprep 150, Sanyo Scientific; n=6). The cell extracts were 
centrifuged, and the protein content was measured by the BCA method. 
Catalase activity was measured using the method of Claiborne, based on the 
breakdown of H2O2 (Clairborne 1985).
Glutathione peroxidase (GPx) activity was measured using the method of 
Flohe and Gunzler (Flohe and Gunzler, 1984).
3.1.4.1 Analysis of protein content of samples:
Protein content of samples was measured by the bicinchoninic acid (BCA) 
method.
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3.1.4.2 Bicinchoninic acid (BCA) method for determination of protein 
content:
Where specified the protein content of samples was determined using the 
bicinchoninc acid (BCA) protein assay kit (Sigma.) This method is based on 
the method developed by Smith (Smith et al, 1985).
Reagents
• Reagent A: Bicinchoninic acid (BCA) solution, containing: 25mM 
BCA-Na, 160mM NaCOs.hhO, 7.0mM Na2 tartrate, 0.1 mM NaOH and 
0.95% NaHCOa, pH 11.2 (Sigma-Aldrich, Dorset, U.K.)
• Reagent B: 160mM CuS04.5H20 (Sigma-Aldrich, Dorset, U.K.)
• Bovine serum albumin (BSA) 1 mg/ml (Sigma-Aldrich, Dorset, U.K
Protocol
A range of standards from 25-250pg/ml were prepared from a stock solution 
of 1 mg/ml bovine serum albumin (BSA). Twenty microlitres of sample or 
standard were placed in a 96 well microplate. Twenty microiitres of dH20 was 
used as a blank. Reagent C was prepared by adding 500pl of Reagent B to 
25ml of Reagent A. Two hundred microiitres of Reagent C was added to the 
samples, standards and blank, the microplate was incubated at 50°C for 
30mins. The absorbance of samples and standards was then measured at 
570nm using a microplate reader (Powerwave X340, Bio-tech instruments 
Inc, Vermont, USA.). The protein content of the samples was calculated 
using the standard curve.
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3.1.4.3 Catalase assay:
Catalase activity was measured spectrophotometricaly using the assay 
developed by
Beers and Sizer (Beers and Sizer, 1952), and used by Claiborne. Catalase 
catalyses the decomposition of hydrogen peroxide to water and molecular 
oxygen. Catalase activity can be measured by the decomposition of 
hydrogen peroxide at 240nm.
Reagents
30% hydrogen peroxide (Sigma-Aldrich, Dorset, U.K)
50mM potassium phosphate buffer, pH 7.0
Protocol
The concentration of the stock 30% hydrogen peroxide was measured on 
each day the assay was performed as it degrades slowly on storage at 4°C. 
The stock hydrogen peroxide was diluted 1 in 800 with dH20 and the 
absorbance at 240nm was measured (CECIL CE594/ Double Beam 
Spectrophotometer, Cambridge, U.K.) against a quartz cuvette containing 
distilled water. The concentration of the stock hydrogen peroxide was 
calculated using the molar extinction coefficient of 43.6M'1cm1 (Claiborne, 
1985). A 19mM hydrogen peroxide solution was prepared in 50mM 
phosphate buffer. Four hundred microlitres of this solution was placed in a 
quartz cuvette, twenty microlitres of sample was added to this and rapidly 
mixed. The decrease in absorbance at 240nm was monitored at room 
temperature over 1-2 minutes. The activity of catalase was determined as 
micromoles of hydrogen peroxide converted per milligram of protein in the
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sample. The conversion of maximum velocity to specific activity of catalase is 
made as follows:
o -r- m . . AA0,nnm per minute x 1000Specific Activity (units/mg) =—240mrt ^----------- :--------
/13.6x mgPrQtem
ml reaction mix
3.1.4.4 Glutathione peroxidase assay:
Glutathione peroxidase was measured spectrophotometrically using a 
method described by Flohe and Gunzler (Flohe and Gunzler, 1984).
Reagents
50mM Tris/HCI pH 7.6
Coupling reagent in 100ml Tris/HCI buffer:
2mM disodium EDTA, 1mM NaN3, 1mM Glutathione (reduced form), 0.2mM 
NADPH, 100 Units glutathione reductase (600U/ml Roche Diagnostics 
Ltd,East Sussex, U.K.)
30% hydrogen peroxide (Sigma-Aldrich, Dorset, U.K.)
Protocol
The concentration of the stock 30% hydrogen peroxide was measured at 
240nm as described for the catalase assay (section 3.1.4.3). A 1mM 
hydrogen peroxide solution was prepared in 50mM Tris/HCI buffer. Ten 
microlitres of sample was added to 575pi of coupling reagent in a quartz 
cuvette, 15pl of hydrogen peroxide was added to this and rapidly mixed. The 
decrease in absorbance at 340nm was measured for 1min (CECIL CE594/ 
Double Beam Spectrophotometer, Cambridge, U.K.). The decrease in 
absorbance of 585pl of coupling reagent with 15pl was used as a blank and
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subtracted from that of the samples. The activity of glutathione peroxidase 
was calculated using the molar extinction coefficient of 6220 M'1cm1.
3.2 MODEL FOR ISCHEMIA REPERFUSION INJURY:
HK-2 cells were seeded in 6 well culture plates as described previously. 
Once 80% confluence was reached, growth was arrested by incubation in 
SFM for 24 hrs. The cells were then incubated with hydrogen peroxide 0.5 
mM for 60 minutes at 37°C in an incubator. Cells were then washed with PBS 
at room temperature three times after the injury period and then incubated in 
growth media for varying time intervals of 6,12,24,and 36 hours. The control 
group were not exposed to hydrogen peroxide but were given PBS wash to 
keep the conditions similar in both groups. The cells were then harvested at 
the above stated time intervals to assess markers of oxidative stress injury 
and adaptation as shown in Figure 3.1.
Markers of Oxidative Stress measured include oxidised and total glutathione 
and protein thiol content of HK-2 cells and Malondialdehyde (MDA) using 
methods established in our laboratory. Adaptive Enzyme Systems measured 
include: The activity of the enzymes catalase, glutathione peroxidase, using 
methods established in our laboratory.
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HK-2 CELLS SEEDING 105 CELLS /WELL 
IN GROWTH MEDIA
i
80 % CONFLUENCE
1
SFM (24hrs)
/ \
CONTROL
1
WASH PBS (3X)
I
INCUBATION IN GM (0-36) HRS INCUBATION IN GM (0-36) HRS
I I
H202 O.SmM (60 min)
i
WASH PBS (3X)
I
CELLS HARVESTED FOR OXIDATIVE STRESS MARKERS
Figure 3.1: Ischemia reperfusion injury model
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3.3 MODEL FOR CHEMOKINE INDUCTION:
HK-2 cells were grown as described previously. 80% confluency was 
achieved and then cells underwent a period of growth arrest for 24 hrs in 
SFM. Oxidative stress was induced by exogenous hydrogen peroxide and 
cells were incubated for 60 minutes with 30 and 300 pM hydrogen peroxide. 
After 60 minutes the cells were washed three times with PBS at room 
temperature. Cells were incubated in SFM for next 24hrs.The supernatant at 
this time point was collected as shown in Figure 3.2. The cells were also 
harvested in NaOH to determine the protein content which was analysed by 
BCA (Sigma). Supernatant was analysed for IL-8, MCP-1 and RANTES using 
Elisa Sandwich techniques (R&D Systems).
HK-2 CELLS SEEDING 10s CELLS /WELL 
INGROWTH MEDIA
i
80 % CONFLUENCE
i
SFM
CONTROL H2O2 (60 min) 30,300pM
WASH PBS (3X) WASH PBS (3X)
i 1
24 HRS INCUBATION 24 HRS INCUBATION
SUPERNATANT 24 HRS
Figure 3.2: Model for chemokine induction
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3.4 Model for chemokine suppression with NAC:
HK-2 cells were grown as described previously. 80% confluency was 
achieved and then cells underwent a period of growth arrest for 24 hrs in 
SFM. A set of these cells (n^S) were incubated with NAC 10mM for 60 
minutes which was washed three times with PBS. The control cells were not 
exposed to NAC but however received a wash with PBS to keep all 
conditions similar in both sets. Cells were then incubated in H2O2 30 and 
300pM for 60 min. After 60 min cells were washed with PBS three times and 
incubated in SFM for 24 hrs. Supernatant was collected and analysed for IL-8 
and MCP-1 using Elisa Sandwich techniques (R&D Systems) as shown in 
Figure 3.3.
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HK-2 CELLS SEEDING 105 CELLS /WELL 
IN GROWTH MEDIA
I
(SFM)
INCUBATION WITH NAC 10mM 
60 min
4
WASH PBS 3 X
1
H2O2 (60 min)
30 AND 300^M
I
WASH PBS 3 X
WASH PBS 3 X
i *
SUPERNATANT 24 HRS SUPERNATANT 24 HRS
80% CONFLUENCE
CONTROL N=3 
1
WASH PBS 3 X
Figure 3.3: Model for chemokine suppression with NAC
3.5 Model for chemokine induction with IL-1 beta and NAC suppression:
HK-2 cells were cultured as described previously. 80% confluency was 
achieved and then cells underwent a period of growth arrest for 24 hrs in 
SFM. A set of these cells (n=3) were incubated with NAC 10mM for 60 
minutes and washed three times with PBS. The control cells were not 
exposed to NAC but however received a wash with PBS to keep all 
conditions similar in both sets. Following this some cells (n=3) were pre­
incubated with IL-1 (3 1 ng/ml for 24 hrs.
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Other cells remained in SFM. Cells were washed with SFM three times and
incubated in FI2O2 30 and 300 micromoles for 60 min. Again cells were 
washed with SFM three times and incubated in SFM for 24 hrs. Supernatant 
was collected and analysed for IL-8 and MCP-1 using Elisa Sandwich 
techniques (R&D Systems) as shown in Figure 3.4.
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HK-2 CELLS SEEDING 105 CELLS /WELL 
IN GROWTH MEDIA
CONTROL
1
WASH 3 X PBS
WASH 3 X PBS
WASH 3 X PBS
1
SUPERNATANT 24 HRS
80% CONFLUENCE (SFM)
INCUBATION WITH NAC 
10mM 60 min
1
WASH 3 X PBS
I
IL-1b 1ngm/ml X 24hrs
1
WASH 3 X PBS
1
H2O2(60 min) 
30 AND 300|iM
I
WASH 3 X PBS
1
SUPERNATANT 24 HRS
Figure 3.4: Model for chemokine induction with IL-1 beta and NAC 
suppression:
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3.6 ELISA METHODS FOR IL-8 (CXCL8):
The assay for measuring IL-8 released into the cell culture media is based on 
a quantitative sandwich enzyme immunoassay technique.
3.6.1 Materials
Capture antibody (R&D DY 208)
Detection antibody (R&D DY 208)
Standard (Recombinant IL-8 protein) (R&D DY 208)
Streptavidin-HRP (R&D DY 208)
PBS
Wash buffer (0.05% Tween 20 in PBS)
Block buffer (1% BSA in PBS)
Reagent diluent (0.1% BSA,0.05% Tween 20 in Tris-buffered saline) 
Substrate solution (1:1 mixture of Colour reagent A and Colour reagent B) 
(R&D DY 999)
Stop solution 2N H2SO4 (R&D DY 994)
Plate covers
Microplate reader (Powerwave X340, Bio-tech Instruments Inc, Vermont, 
USA)
3.6.2 ELISA PROTOCOL:
Plate preparation
Capture antibody was diluted in PBS to a working concentration of 4pg/ml. 
96 well microplate was coated immediately with 100pl per well. The plate 
was sealed and incubated overnight at room temperature. Each well was
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aspirated and washed with wash buffer three times. The plate was blocked 
with 300pl of block buffer for 1 hr. Repeat aspirate and wash three times.
3.6.3 Assay procedure:
The standards were prepared by reconstituting the lyophilised powder, 
provided by the manufacturer (R&D Systems). Serial dilutions were then 
carried out using the same diluent to provide standards of 1000, 500, 250, 
125, 62.5, 31.2 and 15.6pg/ml100ul of sample or standard in reagent diluent 
was added in each well in duplicate and incubated for 2hrs. The process of 
repeat aspirate and wash with wash buffer was performed three times. 100 pi 
of detection antibody was added and incubated for 2 hrs. The process of 
repeat aspirate and wash as above was done three times again. 100 pi of 
Streptavidin-HRP was added for 20 minutes in dark and process of aspirate 
and wash repeated as above. 100 pi of substrate solution was added and 
incubated for 20 minutes in dark to which 50pl of stop solution was added.
3.6.4 Calculation of results:
The plate was read using a microplate reader (Powerwave X340, Bio-tech 
Instruments Inc, Vermont,USA) at 450nm using background subtraction at 
570nm. The concentrations of the unknown samples were determined from 
the standard curve obtained and multiplied by the dilution factor to obtain the 
concentration. These results divided by the total protein concentration 
(mg/ml) gave the total IL-8 concentration in pg/mg protein.
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3.7 ELISA METHODS FOR MCP-1 (CCL2):
3.7.1 Materials:
MCP-1 Microplate - 96 well polystyrene microplate coated with mouse 
monoclonal antibody against MCP-1 
MCP-1 Conjugate
Standard (Recombinant human MCP-1)
Calibrator diluent (RD5L) Concentrate 5X
Wash buffer concentrate
Colour reagent A
Colour reagent B
Stop solution 2N H2SO4
12mmx75mm polypropylene test tubes
Plate covers
Microplate reader (Powerwave X340, Bio-tech Instruments Inc, Vermont, 
USA)
3.7.2 ELISA PROTOCOL:
Reagent preparation
All reagents brought to room temperature before use 20ml Wash buffer 
concentrate diluted with deionised water to prepare 500ml of wash buffer 
20ml of Calibrator diluent (RD5L) diluted with deionised water to yield 100ml 
MCP-1 standard is reconstituted with 5ml of calibrator diluent yielding a 
stock solution of 2000pg/ml. Allow standards to sit for 15 minutes before 
making a serial dilution as shown in Figure 3.5.
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500 pL 500 pL 500 pL 500 mL 500 mL
2000
pg/mL
1000 500 250 125
pg/mL pg/mL pg/mL pg/mL
62.5 31.2
pg/mL pg/mL
Figure 3.5: Showing serial dilution of MCP-1 (CCL2) standard
3.7.3 Assay procedure
200ul of standard and sample was added in each well and incubated for 2 
hrs. Aspiration and wash of each well was done using wash buffer at least 
three times. 200ul of MCP-1 Conjugate was then added to each well and 
incubated for 1hr. The process of aspiration and wash was repeated three 
times again. 200pl of substrate solution was then added to each well and 
incubated for 20 minutes in dark. 50pl of stop solution was then added to 
each well.
3.7.4 Calculation of results
The plate was read using a microplate reader (Powerwave X340, Bio-tech 
Instruments Inc, Vermont, USA) at 450nm using background subtraction at 
570nm. The concentrations of the unknown samples were determined from 
the standard curve obtained and multiplied by the dilution factor to obtain the 
concentration. These results divided by the total protein concentration 
(mg/ml) gave the total MCP-1 concentration in ng/mg protein.
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3.8 Viability:
Cell viability was assessed using the Trypan blue exclusion assay. Adherent 
and floating cells were harvested at 24 and 48 hrs after exposure to either 
SFM alone (control) or to Hydrogen peroxide preparations at concentration of 
30,300 and 1000 pM. The number of live and dead cells (stained blue) was 
counted, and the viability was expressed as the percentage of live cells within 
the total number of cells counted.
3.9 CLINICAL STUDIES
Transplant graft biopsies were collected from patients who were undergoing 
the biopsy procedure due to graft dysfunction, the common indications being 
DGF, Acute cellular rejection, drug toxicity and CAN. An informed written 
consent was procured from all patients. The procedure was done under local 
anaesthesia according to the unit protocol under ultrasound guidance. An 
automatic biopsy gun was used with 16Fr true cut needle. One core of tissue 
was taken for research purposes only if it was safe enough to proceed for an 
extra core and the patient was comfortable and once again gave a verbal 
consent. Some biopsy samples were procured from deceased donor kidneys 
prior to implantation only when the family had given consent for the organ to 
be used for research purposes. Biopsy specimen was snap frozen 
immediately in liquid nitrogen and stored at -70°C until further analysis. 
Samples were later processed for western blot and tested for markers of 
oxidative stress.
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3.9.1 Renal transplant biopsy data:
3.9.2 Western blot:
Biopsy specimens were taken out from the -70°C freezer and ground 
mechanically in liquid nitrogen. Homogenisation buffer (1% SDS, PI 0.5ML, 
and EGTA 9.5mg) was added and the mixture was centrifuged at 16000 g at 
4°C for 10 minutes; the resulting supernatants were stored at -70°C. The 
protein concentration of the sample was determined using the BCA method. 
Aliquots of samples containing 40 pg of total protein were heated for 5 min at 
95°C in denaturing loading buffer. The proteins were then resolved on 4% 
and 12.5% SDS-PAGE mini gels and blotted onto nitrocellulose membranes. 
The membranes were blocked for 1 hr at room temperature in Blotto (5% 
skimmed milk in PBS) supplemented with 0.05% Tween 20 (PBST) and 
exposed at room temperature to primary antibodies using antibody dilutions 
and time period as recommended by the manufacturer. The membranes 
were repeatedly washed in PBST and exposed at room temperature to 
secondary antibodies as recommended by the manufacturer. Protein bands 
were visualized using Super Signal West Dura Extended duration 
chemiluminescent substrate (Pierce/Perbio Science) and recorded using a 
Chemidoc XRS imaging system and Quantity one software (Bio-Rad). The 
intensity of the signal from each band was corrected for background signal 
and expressed as a percentage of the content of control cells.
3.9.2.1 Reagents
Laemmli buffer: 46.03 mg/ml SDS, 20.9% glycerol, 2.1% (v/v) |3- 
mercaptoethanol, 0.052 mg/ml bromophenol blue in 0.128M Tris/HCI buffer, 
pH 6.8.
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3.9.2.2 Protocol
One hundred micrograms of total protein was added to an equal volume of 
Laemmli buffer. Samples were boiled for 5min and then allowed to cool to 
room temperature. Samples were loaded onto a polyacrylamide gradient gel 
alongside a molecular weight rainbow marker (Amersham Biosciences, UK).
3.9.2.3 Preparation of polyacrylamide gradient gels 
Reagents
■ Stock acrylamide solution: 30% acrylamide, 0.8% bisacrylamide 
cross-link, in dh^O (Protogel, National Diagnostics, USA)
■ Gel buffer: 1.5M Tris/HCI, 0.384% SDS, pH 8.8. (Protogel 
buffer, National Diagnostics, USA)
■ Stacking buffer: 0.5M Tris/HCI, 0.4% SDS, pH 6.8. (Protogel 
stacking buffer, National Diagnostics, USA)
■ 12% acrylamide solution (100ml): 40ml stock acrylamide 
solution, 26ml gel buffer, 32.9ml dH20
■ 4% stacking gel solution (100ml): 13ml stock acrylamide 
solution, 25ml stacking buffer, 61ml dH20
■ 10% (w/v) Ammonium persulphate (APS)
■ NNN’N’-tetramethylethylene-diamine (TEMED)
Protocol
12% acrylamide was prepared as described above. One hundred microlitres 
of 10% APS and 10pl of TEMED was added to 10ml of 12% acrylamide 
solution to catalyse gel formation. The gel solution was poured between 
glass plates (8x10cm) with 2mm spacers and allowed to set for 10-15mins.
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The 4% stacking acrylamide solution was prepared as described above. One 
hundred microlitres of 10% APS and 25pl of TEMED was added to 10ml of 
4% acrylamide solution. The 4% gel solution was poured on top of the 12% 
gel to form a 1-1.5cm stacking gel and a well comb was placed in position to 
facilitate sample loading.
3.9.2.4 Electrophoresis of proteins 
Reagents
■ Electrophoresis buffer: 10X Tris/Glycine/SDS (0.025M Tris, 
0.192M glycine, 0.1% (w/v) SDS; National Diagnostics, USA)
Protocol
Electrophoresis was carried out using an Anachem Electrophoresis tank with 
1X electrophoresis buffer. Electrophoresis was carried out at a constant 
current of 20mA per gel until samples had run through the 4% stacking gel; 
the current was then increased to 40mA per gel until the 15KDa molecular 
weight marker had reached the bottom of the gel. The tank was cooled with 
H2O during electrophoresis.
3.9.2.5 Western blotting of separated proteins 
Reagents
■ Anode 1 buffer: 0.3M Tris in a 20% methanol solution, pH 10.4.
■ Anode 2 buffer: 25mM Tris in a 20% methanol solution, pH 
10.4.
■ Cathode buffer: 40mM 6-amino n hexanoic acid in a 20% 
methanol solution, pH 7.6.
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Protocol
The Multiphor II discontinuous blotting system (Pharmacia, Milton Keynes, 
UK) was used to transfer proteins to a nitrocellulose membrane. This system 
consists of two graphite plate electrodes. Following electrophoresis gels were 
removed from the glass plates and the 4% stacking gel was removed. The 
gel was placed on top of a nitrocellulose membrane and this was sandwiched 
between the electrodes with Whatman No 1 filter paper pre-soaked in anode 
and cathode buffers as shown in Figure 3.6. A constant current of 0.8mA/cm2 
was applied to the system for 1,5hrs.
9 filter papers soaked in Cathode buffer
Gel
Nitrocellulose soaked in Anode 2 buffer
3 filter papers soaked in Anode 2 buffer
- 6 filterpapers soaked in Anode 1 buffer
Figure 3.6: Schematic diagram of western blotting
3.9.2.6 Probing of nitrocellulose membrane for protein content 
Reagents
■ PBS solution: 0.05M KH2PO4, 0.05M Na2HP04, 1.3M
NaCI in dH20, pH 7.2.
■ PBS solution: 0.05M KH2P04) 0.05M Na2HP04, 1.3M
NaCI in dH20, pH 6.0.
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PBS/Tween solution: 0.05% (v/v) polyoxyethylene-sorbitan 
monolaurate (Tween 20) in PBS solution.
Blocking solution: 5% (w/v) powdered milk in PBST
Protocol
Following transfer, the nitrocellulose membrane was removed and placed in 
50ml of a blocking solution for either 1 hour at room temperature or overnight 
at 4°C. Membranes were then washed in PBST solution. The nitrocellulose 
membrane was then analysed for oxidative stress markers using a range of 
monoclonal or polyclonal antibodies. The nitrocellulose was agitated for an 
hour in 10ml of a solution of PBST containing the primary antibody at the 
concentration listed in Table 3.1. The membrane was then washed in PBST 
solution for 3x10mins and placed into the appropriate peroxidase labelled 
secondary antibody solution in PBST containing 25% FCS as a non-specific 
blocking agent 1 hour at room temperature. The membrane was then washed 
for 3x10mins in PBST and then for a further 15min in PBS pH6.0 as this is 
the optimal pH for the peroxidase activity. The membrane was developed 
using Super Signal West Dura chemiluminescent detection kit (Pierce, 
Rockford, USA). The membrane was placed between acetate sheets and 
analysed using a Bio-Rad Chemi-XRS System and Quantity One software 
(Bio-Rad, Hercules, USA).
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Table 3.1: The primary and secondary antibodies used in Western 
blotting
Antibody Source Species Primary
antibody
dilution
Incubation
Time/Temp
Secondary
antibody
dilution
Trx (2B1) 
Thioredoxin 
SC-58439
Santa Cruz 
biotechnology
Mouse monoclonal 1:100 1.5 hrs/RT Anti-Mouse
1:5000
TrxRI (A-20) 
Thioredoxin 
reductase 
SC-18220
Santa Cruz 
Biotechnology
Goat polyclonal 1:200 2hrs /RT Anti goat 1:2000
Anti- Cu/Zn 
SOD 
SOD-100
Stressgen Rabbit polyclonal 1:4000 2hrs /RT Anti Rabbit 
1:5000
Glutathione
peroxidase
Ab8850
Abeam Sheep polyclonal 1;1000 2hrs /RT 1:1000
Anti sheep
Thioredoxin
T8690
Sigma Human T- cell, 
recombinant
Thioredoxin2 
Ab16836
Abeam Rabbit polyclonal 1:1000 2hrs/ RT Anti Rabbit 
1;5000
Anti-catalase
C 0979
Sigma Mouse Monoclonal 1:2000 2hrs/ RT Anti mouse 
1:10000
Anti- MnSOD 
SOD 110
Stressgen Rabbit polyclonal 1 ;4000 2hrs/ RT Anti rabbit 
1:5000
Beta actin 
Ab8224
Abeam Mouse monoclonal 1: 5000 1 hr/ RT Anti mouse 
1:5000
3.9.2.7 Primary Antibodies 
Trx (2B1)
Thioredoxin is a mouse monoclonal antibody (Santa Cruz biotechnology, 
USA) catalogue number SC-58439. This antibody is raised against the full 
length of thioredoxin of human origin; molecular weight 12 kDa.
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TrxR1 (A-20)
Thioredoxin reductase is a goat polyclonal (Santa Cruz Biotechnology, USA) 
catalogue number SC-18220. It is recommended for detection of precursor 
and mature thioredoxin reductase of human and to lesser extent rat origin; 
molecular weight 55 kDa.
T8690
Human T- cell recombinant Thioredoxin (Sigma-Aldrich, Dorset, U.K) 
catalogue number T 8690. It is cloned from Jurkat cell cDNA and has a 
molecular weight of 14kDa.
ab16836
Thioredoxin2 is a rabbit polyclonal antibody (Abeam) catalogue number 
ab16836. It reacts against human and mouse species. It is localized in the 
mitochondrion and has a molecular weight of 18 kDa.
SOD 100
Anti- Cu/Zn SOD is a purified rabbit polyclonal antibody that detects Cu/Zn 
superoxide dismutase (Stressgen Inc, Canada). It is recommended for use in 
human samples and has a molecular weight of 23 kDa.
SOD 110
Anti-MnSOD is a rabbit polyclonal antibody (Stressgen Inc, Canada) that 
detects MnSOD; molecular weight 25 kDa.
ab8850
Glutathione peroxidase is a sheep polyclonal antibody (Abeam) purified from 
human erythrocytes and reacts with human glutathione peroxidase with 
bands seen at 23 and possibly 92 kDa.
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C 0979
Anti-catalase is a mouse monoclonal antibody derived from CAT 505 
hybridoma (Sigma-Aldrich, Dorset, U.K). It reacts specifically against human 
catalase; molecular weight of 60kDa.
3.9.2.8 Removing antibodies and re-probing the nitrocellulose
membrane
Reagents
■ 100mM |3-mercaptoethanoi (Sigma-Aldrich, Dorset, U.K.)
- 2% (w/v) SDS
■ 62.5mM Tris/HCI, pH 6.7
■ PBS/Tween solution, pH 7.2
■ Blocking solution containing 5% (w/v) powdered milk PBST
Protocol
Antibodies were removed from the nitrocellulose membrane and the 
membrane was re-analysed for other proteins. After exposure to 
chemiluminescent detection solution (Pierce, Rockford, USA), the membrane 
was washed in PBST solution for 5mins and then incubated in a solution 
containing 100mM p-mercaptoethanol, 2% SDS, 62.5mM Tris/HCI, pH 6.7 for 
30mins at 50°C. The membrane was then washed for 2x10mins in PBST 
solution at room temperature. The membrane was then placed in 50ml of 
blocking solution for 1hr at room temperature or alternatively at 4°Covernight. 
The membrane was then analysed for the content of other oxidative stress 
markers as described above in section 4.2.6.
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3.9.3 Ethical approval:
Ethical approval was granted by the Liverpool (Adult) local research ethics 
committee. REC reference number 01/189, study number 2226. Permission 
for use of clinical biopsies was taken from the patients undergoing renal 
transplant biopsies for any clinical indication after signing an informed 
consent form.
3.9.4 Statistical analysis
Statistical analyses were carried out using the Statistical Package for Social 
Sciences (SPSS version 11.01, Surrey, UK). All data were expressed as 
means ± SE. Data were analyzed using a one-way repeated-measures 
ANOVA. Where a significant value was observed, Tukey’s HSD post hoc 
analysis was performed to identify where the significant differences occurred. 
A P value of <0.05 was considered significant.
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CHAPTER 3
RESULTS: LABORATORY MODEL
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4.1 Oxidative stress model
4.1.1 Glutathione peroxidase activity
HK-2 cells were cultured in six well plates and upon 80% confluence they were growth 
arrested. Oxidative stress was introduced by incubation with 0.5mM of hydrogen 
peroxide for 1 hour. The activity of antioxidant enzyme glutathione peroxidase was 
measured spectrophotometrically. Measurements were made at the time intervals of 
2,4,8,12,24 and 36 hours. The results were expressed in mil per mg of protein. There 
was a significant rise in glutathione peroxidise activity in the samples collected after 
36 hours of injury (p<0.05) as shown in Figure 4.1. The median activity in control 
samples was 95.34 mU/mg (SE23.88) while it was 181.8 mU/mg (SE10.61) in test 
samples at 36 hours. All experiments were repeated on at least three separate 
occasions. The results show that hydrogen peroxide was able to induce direct 
oxidative stress, to which the HK-2 cells responded by activation of antioxidant 
enzyme Glutathione peroxidise.
Glutathione-peroxidase activity with 0.5mM H202 (n=6)
Figure 4.1: Glutathione peroxidase induction with hydrogen peroxide (n=6)
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4.1.2 Catalase activity
Similar to the above experiment, HK-2 cells were exposed to 0.5mM hydrogen 
peroxide for one hour and cells were harvested at time intervals of 2,4,8,12 and 36 
hours to detect the antioxidant enzyme catalase spectrophotometrically as described 
earlier. There was no significant change in the activity of catalase at all time 
intervals.(n=12) as shown in Figure 4.2. There could be several reasons for the lack of 
induction of catalase enzyme. In our laboratory catalase was often seen to respond 
poorly to stimulation in HK-2 cells. Our initial experiments were performed in porcine 
LLCK cell line where catalase had shown favourable response to stimulation. Other 
reasons maybe due to inactivation of catalase by hydroxyl radicals while GPx maybe 
less affected (Pigeolet et al 1990). The concentration of hydrogen peroxide used may 
also affect the oxidative damage. The micromolar concentration maybe more effective 
while we had used milimolar concentration in this experiment.
Catalase activity after hydrogen peroxide (n=6)
i 10 -
Figure 4.2 Catalase activity seen after hydrogen peroxide (n=6)
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4.2 Chemokine model
4.2.1 IL-8 (CXCL8) experiments
4.2.1.1 Basal secretion After sub-culturing the HK-2 cells in 6 well plate once 70-80% 
confluence was reached cells were growth arrested by incubating in serum free 
media. The supernatant was then collected at intervals of 6,12, 24 and 48 hrs. IL-8 
(CXCL8) was detected within 6 hours of incubation 70.3pg/ml (SE36.86) and the 
concentration increased exponentially with time to 456.8pg/ml (SE 94.28) at 12 hours, 
925pg/ml (SE139.1) at 24 hours and 1337pg/ml (SE 158) at 48 hours as shown in 
Figure 4.2. II-8 production from cells that were not stimulated could be due to the 
stress of cell culture, transfer of cells and change in media. The exponential rise with 
time is possibly the effect of accumulation.
Release of IL-8 by unstimulated cells with time (n=3)
2000-1
1500-
1000-
hrs
Figure 4.3: HK2 cells showing basal secretion of IL- 8 (CXC) with time
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4.2.1.2 Effect of Hydrogen peroxide on IL-8 (CXCL8) production
The HK-2 cells were incubated with 30 and 300 fiM of hydrogen peroxide in growth 
media and serum free media separately. No change in IL-8 (CXC) was seen in cells 
which were cultured in growth media (enriched with fetal calf serum) that were 
induced with 30 or 300 pM of hydrogen peroxide. In comparison, cells incubated in 
serum free media induced with 300pM of hydrogen peroxide showed a significantly 
increased production of IL-8 (CXCL8) which was measured at 24 hrs, (p<0.05) as 
shown in Figure 4.4.
The cells could be less stressed in growth media as compared to serum free media 
thus resulting in less response in growth media group. Also the albumin present in 
fetal calf serum may have scavenged the free radicals resulting in poor response in 
growth media group.
o>
£
o>
Q.
IL-8 at 24 h SFM Vs GM (n=6)
0 30 300
H202 [mM]
*P<0.05
Figure 4.4: IL-8 induction with 300pM H2O2 in SFM but not in GM at 24 hrs
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4.2.1.3 Effect of Interleukin-lbeta on IL-8 (CXCL8) production
HK-2 cells were incubated with Interleukin-lbeta (1ng/ml) for 24 hours and 
supernatant collected after 24 hours showed increased production of IL-8 (CXCL8) to 
a significant value of 7989pg/ml(SE534.9) (p<0.05). In the same experiment 30 and 
300 pM of hydrogen peroxide also caused increased production of IL-8 to significant 
levels (p<0.05). In a separate sub-group of cells which were incubated with 
Interleukin-lbeta and then induced with 30 and 300pM hydrogen peroxide a further 
increase in the production of IL-8 (CXCL8) was seen as shown in Figure 4.5 (p<0.05). 
There was no statistical difference between the rise with 30 and 300 mM hydrogen 
peroxide alone but the rise between Interleukin-lbeta stimulated cells followed by 
incubation with 30 and 300 mM hydrogen peroxide group was significant suggesting 
synergism between Interleukin-lbeta and hydrogen peroxide. These results were 
consistent in supernatant collected both at 6 and 24 hrs. (Figure 4.6) Cytokines like IL- 
1p are known to increase IL-8 (CXCL8) production. Hydrogen peroxide is also known 
to increase IL-8 release and both may act through separate signal pathways affecting 
the IL-8 production. When both signal pathways are involved it can lead to synergistic 
increase in IL-8(CXCL8) production.
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Induction of IL-8 with IL-1 and H202
20000-1
15000-
10000-
5000-
300 H IL-1+30 H IL-1 +300 H
Figure 4.5: IL-8 induction with IL-1 alone and in combination with H202(n=6)
* = P <0.05
Comparison of IL-8 at 6 & 24 hrs with IL-1 and H202 
induction(n=6)
■ 6hrs 
□ 24hrs
Control 30 300 IL-1 IL-1+30 IL-1
+300
Figure 4.6: IL-8 induction with IL-1 alone & combined with H2O2 at 6 & 24hrs
*= p<0.05
4.2.1.4 Effect of N-Acetyl cysteine on Hydrogen peroxide induction:
HK-2 cells were pre-incubated with NAC 10mM for 60 minutes. Following this the cells
were stimulated with hydrogen peroxide 30 and 300 pM. IL-8 (CXCL8) was inhibited
in both 30 and 300 mM groups 4464pg/ml (SE425.5) and 3993pg/ml (SE1464)
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respectively as compared to hydrogen peroxide alone groups 5919pg/ml (SE658.7) 
and 6865pg/ml (SE105.5) as shown in Figure 4.7 however this did not reach any 
statistical significance. An interesting paradoxical observation was seen in the NAC 
alone group as IL-8(CXCL8) levels were slightly elevated in this group. NAC in high 
dose can result in oxidative stress itself.
IL-8- NAC preincubation with H202(n=3)
8OOO-1
6000-
4000-
2000-
300H NAC+30H NAC+300H
Figure 4.7: NAC pre-incubation blocking the effect of H2O2 on IL-8 (CXCL8)
There were no statistical differences between data points (P>0.05)
4.2.1.5 lnterleukin-1 beta alone and with N-acetyl cysteine:
HK-2 cells when stimulated with lnterleukin-1 beta 1ng/ml caused significantly increase 
in the production of IL-8 7990pg/ml (SE 972.2) when compared with cells that were 
incubated with culture medium alone 5631pg/ml (SE 154.3)(p<0.05). Further, if the 
cells were pre-incubated with NAC 10mM the induction of IL-1 p could be significantly 
suppressed 5669pg/ml (SE 797.6) p<0.05 as shown in Figure 4.8. This experiment 
proves that IL-1p mediated IL-8 production is partly mediated via oxidative radicals as 
NAC a powerful antioxidant was able to ameliorate this reaction.
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IL-8 induction with IL-1and its inhibition with NAC(n=3)
15000n
10000-
5000-
NAC+IL-1
* p<0.05
Figure 4.8: lnterleukin-1 beta induction of IL-8 (CXC) and its inhibition by pre 
incubation with NAC
4.2.1.6 NAC inhibition of IL-8 (CXCL8) in cells stimulated with both H2O2 and IL-
1P
The above experiments were repeated on a sub-group of cells that were induced with 
IL-ip and also hydrogen peroxide 30 and 300 pM. There was an expected and 
significant increase in IL-8 with IL-1(3 8341pg/ml (SE 711.1) and NAC was able to 
suppress this partially 5500pg/ml (SE 291.5). NAC was also able to inhibit IL-8 
(CXCL8) in cells that were incubated with IL-1 p and hydrogen peroxide (30 and 
300pM). The subgroup that was stimulated with 30pM of hydrogen peroxide were 
seen to inhibited with 10mM NAC but not significantly 2495pg/ml (SE 923.7) vs 
3222pg/ml (SE904.3). The subgroup that was stimulated with 300pM of hydrogen 
peroxide were inhibited significantly by 10mM NAC, 1961pg/ml SE(321.7) vs 
4837pg/ml (SE414.4) as shown in figure 4.9. This result proves the role of oxidative 
stress in mediating IL-8(CXCL8) release with hydrogen peroxide and shows the dose 
related response.
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Inhibition of IL-8 by NAC in cells stimulated by IL-1&H202 (n=3)
8000-
6000-
2000-
* p<0.05
Figure 4.9: Combined effect of NAC pre-incubation on IL-1 and H2O2 stimulated 
cells, N = NAC
4.3 MCP-1 (CCL2):
4.3.1: Induction of MCP-1 (CCL2) with Hydrogen peroxide and lnterleukin-1 beta
Similar to experiments on IL-8 (CXCL8), HK-2 cells were incubated with 30pM and 
300 pM of hydrogen peroxide for 60 minutes in SFM. Supernatant was collected at 24 
hrs. There was no significant change in MCP-1 (CCL2) concentration with hydrogen 
peroxide. In the same experiment when cells were incubated with IL-1p they showed 
a significant increase in MCP-1 (CCL2) 2902pg/ml (SE 67.60) compared to the 
control group, 1616pg/ml (SE 54.54) as shown in Figure 4.10. These results indicate 
that hydrogen peroxide has less involvement in MCP-1 (CCL2) induction as compared 
to IL-8 (CXCL8), however Interleukin -ip was able to potentiate its release suggesting 
different mechanisms maybe involved.
104
MCP-1 induction with IL-1(n=3)
4000-1
3000-
2000-
1000-
H300
p<0.05
Figure 4.10: Induction of MCP-1 (CCL2) with hydrogen peroxide and IL-ip
4.3.1.2 MCP-1 (CCL2) induction with Hydrogen peroxide and IL-ip and inhibition 
by NAC:
In a separate experiment HK-2 cells could be induced with IL-ip to produce MCP-1, 
2902pg/ml (SE 67.60) (p<0.05) but not with hydrogen peroxide (30 and 300 pM) as 
seen in the previous experiment. Pre-incubation with 10mM NAC resulted in inhibition 
of MCP-1 (CCL2) in the group induced by 300 pM of hydrogen peroxide to 793.7pg/ml 
(SE 56.60) but not in 30 pM hydrogen peroxide group, 1172pg/ml (SE 109.2) 
(p<0.05). This suggests oxidative stress involvement which is possibly more complex 
involving several other pathways. Pre-incubation of cells with NAC also resulted in 
inhibition of IL-ip induction although this was not statistically significant as shown in 
Figure 4.11.
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Induction of MCP-1 with H202 & IL-1 & effect of NAC on both (n=3)
3000-
2000-
1000-
H300 N+H30 N+H300 IL-1 N+IL-1
p<0.05
Figure 4.11: MCP-1 (CCL2) induction with Hydrogen peroxide and IL-1B and 
effect of NAC
4.3.1.3 Combined effect of H2O2, IL-ip, and NAC on MCP-1 (CCL2):
The above experiments were repeated similar to the experiment with IL-8 (CXCL8) 
with the addition of a group which was stimulated with IL-1p and hydrogen peroxide 
(30 and 300 pM) and a subset was pre-incubated with 10mM NAC. In repeat 
experiments results were similar to before. IL-ip significantly increased the MCP-1 
(CCL2) release to 2902pg/ml (SE 67.60) and NAC was able to inhibit to 2818pg/ml 
(SE 260.8) although again this increase was not statistically significant. In the subset 
which were induced with hydrogen peroxide and IL-1, NAC pre-incubation produced a 
reduction of MCP-1 (CCL2) in 300 pM group to 1044pg/ml (SE 303.4) when 
compared with the set which did not get NAC, 2636pg/ml (SE 177.4) (p<0.05). The 
group which were incubated with 30pM did not show any significant change as shown 
in Figure 4.12. Again these results show the involvement of oxidative stress in 
induction and suppression of MCP-1 (CCL2).
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MCP-1 induction with IL-1& H202 and inhibition of both with NAC (N=3)
4000-1
3000-
2000-
1000-
p<0.05
Figure 4.12: Combined effect of NAC pre-incubation on IL-1p and H2O2 
stimulated cells
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4.4 Cell Viability:
Cell viability was assessed using the Trypan blue exclusion assay. Adherent and 
floating cells were harvested at 24 and 48 hrs after exposure to either SFM alone 
(control) or to Hydrogen peroxide preparation. The pooled adherent and nonadherent 
cells remained viable both at 24 and 48 hours after exposure to 30,300,1000 pM 
hydrogen peroxide with no significant difference between the three groups as shown 
in figure 4.13.
Viability test at 24 & 48 hrs
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□ 24hrs 
■ 48hrs
control 30mM H202 300mM H202 1000mM
H202
Figure 4.13: Viability test at 24 and 48 hrs with hydrogen peroxide
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CHAPTER 4
RESULTS: CLINICAL MODEL
61 renal allograft biopsies were collected from renal transplant recipients who were 
undergoing this procedure for various clinical reasons. 47 of these biopsies were 
analysed and their data is presented. Biopsy samples that were not included in the 
analysis were used in initial trial runs and some were lost during processing. 21 pre­
implantation biopsies were procured from deceased donor kidneys. 17 of these were 
included in the final analysis as the rest were used in initial trial runs. Data is shown in 
Table 5.1.
Table 5.1: Showing the number of donor and allograft biopsies
Donor biopsies Allograft biopsies Total
Number of biopsies collected 21 61 82
Number of biopsies analysed 17 47 64
5.1 Demography of renal transplant recipients
There were 20 (42.6%) females and 27 (57.4%) males. Median age of the recipients 
was 44.6 yrs ± 2.13 (19.4-76.9). 35 (74.5%) patients underwent renal transplantation 
from a deceased donor while the remaining 12 (25.5%) underwent a living donor renal 
transplantation. 11 patients had a first renal transplant from a living donor. 1 patient 
had a third renal transplant from a living donor. 29 patients had their first renal 
transplant from a deceased donor. 5 patients had a second renal transplant while 1 
patient had a third renal transplant from a deceased donor as shown in Table 5.2.
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Table 5.2: Showing the number of transplant and source of organ
Source of organ Frequency Percent
L1( First living) 11 23.4
T1 (First deceased) 29 61.7
T2(Second deceased) 5 10.6
T3(Third deceased) 2 4.3
Total 47 100.0
5.1.1 Etiology of chronic renal failure:
Chronic glomerulonephritis 13 (27.7%) was the commonest cause of chronic renal 
failure leading to end stage renal disease. Chronic pyelonephritis was seen in 8 (17%) 
and adult polycystic kidney disease was seen in 5 (10.6%). All various other etiologies 
leading to chronic renal failure are detailed in Table 5.3.
Table 5.3: Etiology of chronic renal failure
Basic disease causing chronic renal failure Frequency Percent
ADPKD (Polycystic kidney disease) 5 10.6
CGN (Chronic glomerulonephritis) 13 27.7
CPN (Chronic pyelonephritis) 8 17.0
DRUG ABUSE 1 2.1
HYPERTENSION 5 10.6
IgA NEPHROPATHY 2 4.3
REFLUX NEPHROPATHY 4 8.5
SLE 1 2.1
TYPE1 Diabetes Mellitis 1 2.1
UNKNOWN 6 12.8
VASCULITIS 1 2.1
Total 47 100.0
5.1.2 Clinical indications for biopsy:
The most common indication for undergoing the renal biopsy procedure was renal 
dysfunction which was usually indicated by a rise in serum creatinine of at least 10%.
Ill
34 (72.3%) patients had renal dysfunction, 8 (17%) patients had delayed graft function 
(DGF), 4 (8.5%) had renal dysfunction associated with proteinuria and 1 patient 
underwent biopsy due to proteinuria without an associated renal dysfunction as 
shown in Table 5.4. Median time between the date of transplantation and biopsy was 
157 days ±275.7 (6-8878).
Table 5.4: Showing clinical indications for biopsy
Clinical reason for biopsy Frequency Percent
Rise in Creatinine 34 72.3
Rise in Creatinine+proteinuria 4 8.5
DGF 8 17.0
Proteinuria 1 2.1
Total 47 100.0
5.1.3 Histological diagnosis:
Histological diagnosis was available for all of the 47 allograft biopsies. Chronic 
allograft nephropathy (CAN) was seen in 14(29.8%), Acute Tubular Necrosis (ATN) 
was seen in 5(10.6%). Acute cellular rejection was seen in 19(40.4%) of which 7 
were borderline, 9 Gradela and 3 showed Grade 2a. Cyclosporine toxicity (CYA) was 
seen in 4(8.5%) and other various diagnosis are shown in Table 5.5. Banff 97 
classification (Solez K, 2008) was used to score the grade of acute cellular rejection 
and chronic changes in all of the allograft biopsies as shown in Table 5.6.
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Table 5.5: Histological diagnosis
DIAGNOSIS ON BIOPSY NUMBER
Acute tubular necrosis (ATN) 5(10.6%)
Borderline Rejection 7(14.9%)
Chronic Allograft Nephropathy (CAN) 14(29.8%)
Cyclosporine toxicity (CYA) 4(8.5%)
Acute rejection (Grade 1 A) 9(19.1%)
Acute Rejection (Grade2A) 3(6.4%)
Haemolytic uremic syndrome (HUS) 1(2.1%)
IgA Nephropathy (IgA) 2(4.3%)
Normal 1(2.1%)
Post transplant lymphoproliferative disease (PTLD) 1(2.1)
Total 47
Descriptive variables are reported as percent
Table 5.6: Banff scoring of acute rejection and chronic changes
No of glomeruli 9.152 ±0.60
No of arteries 2.239±0.16
Glomerulitis (g) 0.130±0.05
Interstitial inflammation (i) 0.891±0.13
Tubulitis (t) 0.565±0.11
Intimal arteritis (v) 0.065+0.03
Glomerulopathy (eg) 0.108+0.06
Interstitial fibrosis (ci) 0.673±0.13
Tubular atrophy (ct) 0.587±0.13
Fibro-intimal thickening (cv) 0.326+0.09
Arteriolar hyalinosis (ah) 0.489±0.11
Mesangial matrix increase (mm) 0.260±0.07
Continuous variables are reported as mean ± standard error of means
5.1.4 Immunosuppression:
Most of the patients were on a combination therapy of various immunosuppessive 
drugs as per the protocol and clinical indication for each individual patient. 
Calcineurine inhibitors (Cyclosporine or Tacrolimus) based immunosuppression 
formed the basis of most of the immunosuppressive therapy (91.4%). Predisoione,
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Mycophenolate Mofetil (MMF) and Cyclosporine (Neoral) was the most common 
combination, 9 (19.1%) and Neorai monotherapy was given seen in 9 (19.1%). 
Complete details of the rest are shown in Table 5.7.
Table 5.7: Immunosuppression therapy
Immunosuppression regime Frequency Percent
Azathioprine+Prednisolone 1 2.1
Azathioprine+Prednisolone+Neoral 2 4.3
MMF+Neoral 8 17.0
Neoral 9 19.1
Prednisolone+MMF 1 2.1
Prednisolone+MMF+Azathioprine 1 2.1
Prednisolone+MMF+Neoral 9 19.1
Prednisolone+Neoral 2 4.3
Rapamycin 1 2.1
Tacrolimus 1 2.1
Tacrolimus+MMF 8 17.0
Tacrolimus+MMF+.Prednisolone 3 6.4
Tacrolimus+Rapamycin+Prednisolone 1 2.1
Total 47 100.0
5.1.5: Analysis of graft biopsies for oxidative stress:
109 biopsy samples were analysed. The following proteins were detected: 
Catalase kd-60 60 samples
MnSOD 25-kd 68 samples
CuZnSOD 23-kd 58 samples
Thioredoxin reductase 55 kd 58 samples 
Thioredoxin(2b1) 12kd 51 samples 
Thioredoxin kd62 21 samples
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5.2 Western Blot results for oxidative stress markers from clinical biopsies:
Western blot analysis was done on several gels due to the large number of samples. 
On each gel samples were loaded from different clinical conditions. Beta actin was 
used as loading control.
For quantification purposes each gel had at least one sample from a chronic allograft 
nephropathy labelled as can which was used as a control as there was no adequate 
control biopsy. Donor biopsies were labelled as D, acute cellular rejection as acr, 
cyclosporine toxicity as cya and the biopsy reported as normal was labelled as n. 
Quantification graphs were produced as a percent change from chronic allograft 
nephropathy sample from each individual gel by performing densitometry. Data was 
analysed using Graphpad prism 5 software.
5.2.1 Gel 1:
Gel 1 was probed with various anti oxidant enzyme antibodies which were positive for 
MnSoD, CuZnSoD, Catalase and Thioredoxin reductase. For quantification purpose, 
one biopsy which was reported as normal, one biopsy with IgA nephropathy and 2 
with CAN were grouped together and results were expressed as a percentage change 
compared to this group.
There were 2 biopsies from acute rejection and donor group. CuZnSoD density was 
higher in biopsies taken from acute cellular rejection and pre-implantation donor 
kidneys when compared to samples from CAN.
However only donor biopsy samples showed a significant increase (p<0.05) as shown 
in figure 5.1.
MnSod also was increased in both donors and acute cellular rejection but did not 
reach statistical significance.
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Catalase and Thioredoxin reductase were also increased in acute cellular rejection 
and donor biopsies (p=not significant). Thioredoxin reductase was elevated in acute 
rejection compared to donor biopsy.
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Figure 5.1:
Quantification of Cell showing CuZnSoD, MnSoD, Catalase & Thioredoxin 55
* P<0.05
5.2.2 Gel 2:
Western blot was positive for MnSoD, CuZnSod and Thioredoxin reductase55.
Biopsies having acute injury like acute tubular necrosis and Haemolytic uremic
syndrome were grouped together as ATN for quantification purpose.
There was a significant rise of MnSoD in donor samples and acute rejection samples
(p<0.05) as shown in figure 5.2. Both CuZnSoD and Thioredoxin reductase 55 were
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seen to be more in acute rejection, ATN and donors but not reaching statistical 
significance in any of them.
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100(h
Thioredoxine55 MnSod CuZnSod
Figure 5.2: Quantification of Gel-2 showing MnSoD, CuZnSoD and Thioredoxin 
reductase
* P<0.05
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5.2.3 Gel 3:
MnSod, CuZnSoD and thioredoxin reductase were positive. This gel had samples 
from cyclosporine toxicity (3), acute rejection (4), CAN (3). There were no samples 
from deceased donor kidneys or with ATN. MnSoD was increased in ACR and CYA 
group. Thioredoxin reductase 55 was also increased in ACR and CYA. CuZnSoD was 
also increased in ACR group but less than that seen in CYA as shown in Figure 5.3.
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Figure 5.3: Quantification of Gel3 showing MnSod, CuZnSoD and Thioredoxin 
reductase
5.2.4 Gel4:
Catalase and thioredoxin12 were positive. There were 4 biopsies from CAN and 4 
from ACR and 3 from CYA group. Catalase was slightly higher in CYA group but not
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in ACR. Similarly Thioredoxin was also higher in CYA group but not in ACR as shown
in figure
5.4.
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Figure 5.4: Quantification of Gel4 showing Catalase and Thioredoxin12
5.2.5 Gel 5:
MnSod, CuZnSoD and thioredoxin reductase were positive. There were 2 samples 
from CAN,6 samples from ACR,1 sample from donor and CYA each. For 
quantification the solitary CYA sample was grouped with ACR. MnSoD was increased 
in donor and ACR. CuZnSod was slightly higher in donor group but thioredoxin
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reductase did not show any difference between the three groups as shown in figure
5.5.
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Figure 5.5: Quantification of Gel 5 showing MnSoD, CuZnSoD and Thioredoxin 
reductase 55
5.2.6 Gel 6:
Catalase and Thioredoxin 12 were positive. There were 2 biopsies from CAN and 5 
from ACR, one sample from CYA and donor. For quantification CYA was grouped with 
ACR.
Catalase and thioredoxin did not show any significant change when compared with 
CAN as shown in figure 5.6.
120
D acr can can acr acr acr acr cya
42kd beta-actin 
60kd Catalase
12kd
Thioredoxine
Gel6 (n=9)
Catalase Thioredoxine 12
Figure 5.6: Quantification of Gel 6 showing catalase and thioredoxin 12
5.2.7 Gel 7:
Positive for catalase, MnSoD.CuZnSoD and thioredoxin reductase 55. There were 3 
biopsies from donor group, 3 from CAN,2 from ATN and 2 from ACR. One biopsy from 
ATN also showed ACR. For quantification this was pooled with ATN.
Catalase was significantly higher in the donor group (p<0.05). CuZnSoD was also 
significantly higher in the donor group when compared to ACR and ATN groups but 
not when compared to the CAN group. Thioredoxin reductase was also significantly 
higher in donor group when compared to the ATN and ACR groups but not when
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compared with CAN, similar to the pattern seen with CuZnSoD. Donor MnSod showed 
a significant rise when compared to all other group as shown in figure 5.7 (p<0.05).
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Figure 5.7: Quantification graph of Gel 7 showing MnSod, CuZnSoD, Catalase 
and Thioredoxin reductase 55
* P<0.05
5.2.8 Gel 8:
Positive for Catalase, CuZnSoD, MnSoD, thioredoxin reductase. 4 biopsies were in 
CAN group, 3 were from ACR, 3 from the donor group and one had HUS. HUS biopsy 
was excluded from quantitative analysis. MnSoD was increased in both the donor 
and ACR group when compared with CAN which was statistically significant between 
CAN and ACR only (p<0.05)
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Catalase, CuZnSoD and Thioredoxin reductase all were slightly raised in Donor and 
ACR but not significantly as shown in figure 5.8.
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Figure 5.8: Quantification graph of Gel 8 showing Catalase, CuZnSoD, MnSoD, 
Thioredoxin55
* P<0.05
5.2.9 Gel 9:
Positive for Thioredoxin reductase 62 and thioredoxin 1. There were 4 samples from 
donors, 3 from CAN, 3 from ACR, and 1 from ATN. For quantification ATN was 
grouped with the donor group.
Thioredoxin 2b1 was increased in the donor and to a lesser extent in the ACR group. 
Thioredoxin reductase was increased in ACR and to a lesser extent in the donor 
group (p>0.05) as shown in figure 5.9.
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Figure 5.9: Quantification graph for Gel 9 showing Thioredoxin reductase 62kd 
and Thioredoxin 2b1
5.2.10 Gel 10:
Positive for Catalase, MnSoD, Thioredoxin 2b1.2 samples were from CAN, 6 from 
donors and 2 from ACR. MnSoD was higher in the donor group. Catalase and 
thioredoxin 2b1 did not show any difference when compared with the CAN group as 
shown in figure 5.10.
124
can d d d d d d can a a
42kd beta-actin
60kd catalase 
25kd MnSoD
12kd
Thioredoxine2b1
Gel-10(n=10)
200-i
150-
100-
can donor acr can donor acr can donor acr
catalase MnSod Thioredoxine 2b 1
Figure 5.10: Quantification graph for Gel 10 showing Catalase, MnSoD and 
Thioredoxin 2b1
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5.2.11 Gel 11:
Positive for Thioredoxin reductase 62 and thioredoxin 12. There were 2 samples from 
CAN, 5 donors, 2 ACR and 1 ATN. For quantification ATN was grouped with ACR. 
Thioredoxin 62 was higher in the donor group than in ACR P>0.05). Similarly 
thioredoxinl was also higher in donor group but not significantly as shown in Figure 
5.11.
atn c d
42kd beta-actin
63kd Thioredoxine 2 
reductase
12kd Thioredoxine-1
Gel-11 (n=10)
donor donor
Thioredoxine62 Thioredoxine2b1
Figure 5.11: Quantification of Gel 11 showing thioredoxin 62 and thioredoxin 
2b1
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The results of all western blots were combined and plotted together. Mnsod, CuZnSod 
and Trx55 were increased in deceased donor, acute rejection and cyclosporine 
toxicity but did not reach statistical significance. All enzymes tested showed a reduced 
expression in chronic allograft nephropathy as shown in figure 5.12.
Catalase MnSoD Trxl2 Trx62 CuZnSoD Trx55
p>0.05
Figure 5.12: Comparison graph of all biopsy data
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CHAPTER 5
DISCUSSION
6. Chronic Kidney Disease: 
incidence and burden
Chronic kidney disease consistently affects 10-15% of the general population and the 
incidence of renal replacement therapy varies from around 100-120 per million of the 
population (Caskey et al, 2010). End stage kidney failure creates a huge health and 
economic burden to the nation with sufferers experiencing poorer than average health 
status and quality of life. Data from the UK Renal Registry shows that since 2000 
there has been a 5% annual increase in prevalence of people requiring renal 
replacement therapy, amounting to 2% of the total National Health Service budget 
(Galliford and Game, 2009).
It has been known for several decades that transplantation is associated with both a 
survival and quality of life benefit for recipients when compared with age and health 
matched patients receiving other modalities of renal replacement therapy (Wolfe et al, 
1999).
Health economics are increasingly important in modern healthcare provision. Renal 
transplantation can be heralded as an excellent example of healthcare technology 
that is cost saving and cost effective when compared to dialysis, and so the promotion 
of renal transplantation has an additional societal gain (Zelmer, 2007).
Increasing numbers of renal transplants are being performed. During 2009, 2600 
kidney or kidney plus other organ transplants were performed in the UK, a 5% rise 
from the previous year (Webb et al, 2011).
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6.1 DGF:
6.1.1 Incidence
Ischemia-reperfusion injury is an inevitable event accompanying kidney 
transplantation. It often leads to acute, ischemic tubular injury which manifests 
clinically as delayed graft function. The incidence of DGF is variable depending on the 
criteria used to define it. Halloran & Hunsicker reported a DGF rate of 20-29% in 
cadaver kidneys from the across the transplant centres in USA (Halloran and 
Hunsicker, 2001). Gavela Martinez et al from Spain have recently reported an 
incidence rate of 36.8% (Gavela Martinez et al, 2011).
The frequency of DGF in cadaver transplants has declined only slightly, from about 29 
to 23% over the past decade. In contrast, acute rejection rates have fallen more 
steeply, and the fall in acute rejection has probably accounted for the improvement in 
survival. The incidence of DGF is about 6% in kidneys from living donors, higher than 
is generally realized (Halloran and Hunsicker, 2001).
6.1.2 Sequelae of DGF
Although the true long-term clinical importance of DGF has been debated, Yarlagadda 
et al published a meta-analysis showing DGF is associated with a 41% increased risk 
of graft loss at a mean 39,635 patient-years of follow-up and a 38% increased risk of 
acute rejection (Yarlagadda et al, 2009). Similarly Boom et al showed DGF influences 
long term renal function (Boom et al, 2001).
6.1.3 Pathophysiology of DGF:
The usual histological findings in DGF are of acute tubular necrosis (ATM), similar to 
ATN in native kidneys. Transplant ATN differs from native kidney ATN in having fewer 
tubular casts, occasional necrosis of complete tubular cross-sections, less tubular
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dedifferentiation and regeneration, more calcium oxalate crystals, and more 
microcalcification and isometric vacuolization (possibly due to calcineurin inhibitor 
toxicity) (Olsen et al, 1989).
Cold ischemia and reperfusion during renal transplantation result in release of reactive 
oxygen species. Oxidative stress resulting from IRI has been shown by many studies 
to have a major role in causing DGF (Ahlenstiel et al, 2006).
In normal conditions, the body systems can easily detoxify the produced ROS with 
endogenous antioxidants such as SOD and CAT. However, if there is a pathological 
condition, like IRI, ROS is produced more than usual. A number of studies have 
demonstrated that higher or lower levels of endogenous antioxidants, decrease or 
increase the sensitivity to cell injury concomitantly (Markey et al, 1990; Lash and 
Tokarz, 1990). IRI has provoked wide interest and several studies have investigated 
IRI in several animal and cell culture models.
6.2 Simulated IRI and cell culture:
Creation of a simulated condition of oxidative stress was attempted within the 
constraints of a laboratory model. Human proximal tubular cells (HK-2) were chosen 
for the purpose of these experiments because of their proven track record, durability 
and predicted physiological response. Histochemical, immune cytochemical, and 
functional characteristics have shown that these cells reproduce experimental results. 
IRI was simulated by incubating HK-2 cells with hydrogen peroxide. 0.5 mM of 
hydrogen peroxide was used for inducing anti-oxidant enzymes. Hydrogen peroxide 
when introduced exogenously is known to permeate through cell membranes and 
produce oxidative stress (Giorgio et al, 2007). High concentration of ROS cannot be 
detoxified to water by the intra-cellular antioxidant enzymes. Increased production of 
O2" leads to H2O2, and non-detoxified H2O2 reacts with Fe2+ (known as the Fenton
131
reaction) to produce -OH, which is the most toxic ROS to cellular organisms in the 
oxidative system.
Hydrogen peroxide is also a normal metabolite important for intra cellular signalling 
and is produced by SODs during the dismutation of superoxide anion (Halliwell and 
Gutteridge, 1984). It is also produced by TNF-ct and cytokines to increase their own 
activities (Fiers, 1991).
Miguel et al have utilised hydrogen peroxide in a cell culture model of HeLa cells. 
They have shown acute and chronic treatment with hydrogen peroxide induced 
oxidative stress in a time and concentration dependent manner which was prevented 
with the use of anti-oxidants ascorbic acid and N-acetylcysteine (Miguel, Augusto, and 
Gurgueira, 2009).
Similarly Harrett et al also showed that prior exposure to sublethal H2O2 confirmed an 
adaptive response, resulting in a greater cellular resistance to subsequent toxic 
exposures. They also observed greater catalase, GPx, and CuZnSOD enzymatic 
activity and increased DMA protection (Jarrett and Boulton, 2005).
6.3 Antioxidant enzymes:
6.3.1 Glutathione peroxidase (GPx):
In these experiments HK-2 cells were subjected to exogenous oxidative stress by 
incubation with 0.5mM Hydrogen peroxide for 1 hour. They responded by showing an 
increased production of the antioxidant enzyme glutathione peroxidase. Glutathione 
peroxidase activity was increased in two phases one at 2 hrs and a bigger second 
peak at 24 hrs which was also statistically significant. GPx is an important enzymatic 
antioxidant enzyme. Cytosolic GPx is a selenoprotein that requires several secondary 
enzymes and co-factors (reduced glutathione, NADPH and glucose 6-phosphate) to 
function at high efficiency. There are also five GPx isoenzymes (de Haan et al, 1998).
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Extra cellular GPx has been mainly shown to be produced in kidneys and HK-2 cells 
in cell cultures have been proven to be its source (Avissar et al, 1994), (Whitin et al, 
2002). Several studies have reported involvement of GPx in oxidative stress in 
proximal tubules (van de Water, Zoeteweij and Nagelkerke, 1996; Zhu et al, 2008). 
Sheldon et al have investigated the role of hydrogen peroxide in neonatal head injury, 
and showed GPx1 plays an important role in the defense against hydrogen peroxide 
and is thereby neuroprotective (Sheldon, Christen and Ferriero 2008).
Bose et al showed that an increased antioxidant defence through higher GSH content 
and greater of enzymes such as Cu-ZnSOD, catalase and GPx, provided protection 
from hydrogen peroxide in a cell culture model of a hamster cell line (Bose 
Girigoswami, Bhaumik and Ghosh, 2005).
Ng et al investigated the removal of hydrogen peroxide by GPx. The rate of removal of 
hydrogen peroxide increased with increasing GPx and they found that the rate of 
removal of hydrogen peroxide is affected by GPx and GSH (Ng et al, 2007).
6.3.2 Catalase:
In the present experiments with HK-2 cells, hydrogen peroxide failed to induce 
catalase activity. There could be several reasons for this but other studies have also 
shown catalase to be less responsive in experimental oxidative stress conditions and 
have postulated that it could be due to differential inhibition (Miguel, Augusto and 
Gurgueira 2009). Catalase is also reported to be inactivated by hydroxyl radicals while 
GPx and SOD are considerably less affected by these radicals (Pigeolet et al, 1990). 
Nitric oxide has also been shown to reduce catalase activity (Brown, 1995), (Raicevic 
et al, 2010).
The concentration of hydrogen peroxide used may also affect oxidative damage and 
micromolar concentrations of hydrogen peroxide (100 pM) may induce oxidative DNA 
damage more efficiently than millimolar concentrations (Nakamura, Purvis and
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Swenberg, 2003). In this study millimolar concentrations were used for testing the 
anti-oxidant enzymes but micromolar concentrations were used for chemokine 
induction.
Cultured cells are also known to have reduced sensitivity when compared to intact 
renal tubular cells (Kim et al, 1998).
6.4 IL-8 (CXCL8) and Hydrogen peroxide:
In the second part of the model the induction of chemokines in response to oxidative 
stress was investigated. Basal secretion of IL-8 (CXCL8) was present in the 
supernatant which was higher in samples taken from serum free media. The basal 
secretion of IL-8 (CXCL8) is possibly the response of the cells to normal stress of 
growth inherent in cell culture system.
Bioprocess forces are known to be encountered during cell culture and include 
hydrodynamic shear caused by shaking of the flasks to aid their detachment following 
trypsinisation, forces produced during centrifugation prior to resuspending and shear 
stresses resulting from transfer through capillaries or by pipetting to resuspend cell 
pellets (Veraitch et al, 2008).
Recent evidence has shown that bioprocess forces produced during capillary transfer 
or pipetting of cell suspensions can enhance osteogenic responses and are 
considered to be harmful to cells (Brindley et al, 2011).
These experiments showed that IL-8 (CXCL8) as measured by ELISA increased after 
incubation with 30 and 300 pM of hydrogen peroxide in a dose dependent manner. IL- 
ip alone significantly increased IL-8 (CXCL8) more than with hydrogen peroxide 
alone. The IL-ip and 300pM hydrogen peroxide combination induced IL-8 (CXCL8) 
more than the combination of 30pM H202and IL-ip showing a synergy between IL-1(3 
and hydrogen peroxide.
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Hydrogen peroxide is known to increase IL-8 (CXCL8) production in a variety of 
cells. Similar to our results of an increase in IL-8 (CXCL8) after hydrogen peroxide 
treatment, Andreucci et at also found an increase in IL-8 (CXCL8) after hydrogen 
peroxide stimulation in HK-2 cells (Andreucci et al, 2009). Shimada et al showed a 
similar rise in IL-8 (CXCL8) from gastric epithelial cells when stimulated with hydrogen 
peroxide (Shimada etal, 1999).
DeForge et al also showed the stimulatory effect of hydrogen peroxide on IL-8 
(CXCL8) production by HepG2 cells, A549 pulmonary type II epithelial cells, and 
human skin fibroblasts (DeForge et al, 1993).
6.4.1 Intracellular signal pathways
ROS, apart from altering the oxidative mechanisms also cause activation of the intra­
cellular pathways that cause inflammation. NF-kB is a critical signalling molecule in 
H2O2 induced inflammation and in responses produced by a variety of stimuli that 
include growth factors, lymphokines, ultraviolet irradiation, pharmacological agents, 
and oxidant stress. NF-kB is maintained as a latent form in the cytoplasm of cells 
where it is complexed to I-kB inhibitor proteins; NF-kB activation involves the 
phosphorylation and subsequent degradation of the inhibitory protein I-kB as well as 
the phosphorylation of p65 protein. Thus, released NF-kB dimer can translocate into 
the nucleus. In the nucleus, NFkB binds with consensus sequences of various genes, 
activating their transcription (Gloire, Legrand-Poels, and Piette, 2006).
Similarly Enesa et al showed the mechanism for the pro-inflammatory effects of H2O2, 
prolonged the nuclear localization of NF-kB in activated cells by suppressing the 
negative regulatory functions of kBa (Enesa et al, 2008).
Some authors have also linked activation of JNK pathway to be up-regulated by ROS 
(Kunduzova et al, 2002). Fernandes et al showed the similar role of several signaling
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pathways, such as NF-kB, p38 and MARK in oxidative stress-induced up-regulation of 
IL-8 (CXCL8) in retinal cells (Fernandes et al, 2008).
Kina et al showed Fe2+ mediated ERK pathway activation as an important signal 
transduction pathway in ROS-induced IL-8 secretion in epithelial cells (Kina et al, 
2009).
Expression of chemokines, such as IL-8(CXCL8), which attracts granulocytes into the 
graft, thereby causing further damage to the tissues as they themselves produce more 
ROS and chemokines. Infiltrating inflammatory cells may also release transforming 
growth factor (TGF-pi), platelet-derived growth factor and fibroblast growth factor-2 
which stimulate resident fibroblast cells to proliferate and release excessive 
extracellular matrix (Furuichi et al, 2008; Araki et al, 2006).
An increase of interleukin-8 mRNA expression after l/R both in syngeneic and 
allogeneic transplantation was associated with a marked infiltration of granulocytes in 
renal tissue. A CXCR2 inhibitor, repertaxin, was effective in preventing granulocyte 
infiltration and renal function impairment (Cugini et al, 2005).
6.4.2 Hydrogen peroxide and IL-ip (synergism) :
Cytokines like IL-1 beta, TNF or the bacterial product LPS in both a time- and dose- 
dependent manner are known to increase expression of IL-8 (CXCL8) mRNA and 
secreting IL-8 (CXCL8) peptide (Schmouder et al, 1992).
Ivison et al proved the link and mechanism of hydrogen peroxide mediated IL-8 
(CXCL8) induction. This was dose dependant and associated with synergistic 
phosphorylation of p38 MAP kinase and with prolonged I-kB degradation and NF-kB 
activation (Ivison et al, 2010).
Li et al have also showed that redox regulation of NIK by hydrogen peroxide is 
mechanistically important in IL-1 beta induction of NFkB activation (Li and Engelhardt, 
2006). Enesa et al observed that 100 pM H2O2 combined with cytokines (IL-1p, TNFa)
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induced IL-8 (CXCL8) in synergy in cultured epithelial cells. They also observed that 
the capacity of H2O2 to enhance IL-8 (CXCL8) induction in response to TNFa was 
suppressed in cultures that were pretreated with the anti-oxidant A/-acetyl-cysteine 10 
mM (Enesa et al, 2008).
H2O2 had a significant positive modulatory effect a synergism on the activation of NF- 
kB by TNF-a (de Oliveira-Marques et al, 2007).
6.4.3 Inhibitory role of hydrogen peroxide:
In these experiments involving both IL-8 (CXCL8) and MCP-1 (CCL2), inhibition of 
both was seen when a high dose of hydrogen peroxide, 300 juM, was used in 
combination with IL-1(3. Higher levels of oxidative exposure can turn a potential 
positive stimulus by H2O2 into an inhibitory effect (de Oliveira-Marques et al, 2007) 
and this maybe the reason we detected significant inhibition when high dose of 
hydrogen peroxide was used with MAC.
H2O2 has a fine-tuning regulatory role, comprising both a pro-inflammatory control 
loop that increases pathogen removal and an anti-inflammatory control loop, which 
avoids an exacerbated harmful inflammatory response (de Oliveira-Marques et al, 
2007).
6.5 MCP-1 (CCL2)
These experiments showed MCP-1 (CCL2) could be induced with IL-1(3 alone and in 
combination with SOOpM hydrogen peroxide potentiated this response. There was a 
synergistic response when IL-1p and 300juM hydrogen peroxide were combined. MAC 
could partially suppress the induction of both IL-1p alone and combination of IL-1p 
with hydrogen peroxide. MCP-1 (CCL2) is one of the key chemokines that regulate 
migration and infiltration of monocytes/macrophages. Migration of monocytes from the 
blood stream across the vascular endothelium is required for routine immunological
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surveillance of tissues, as well as in response to inflammation (Deshmane et al, 
2009).
HK-2 cells have been shown to express MCP-1 (CCL2) mRNA and protein. The 
mRNA expression increases with exposure to calcium oxalate crystals. Catalase and 
superoxide dismutase reduces MCP-1 (CCL2) expression suggesting the involvement 
of ROS in its regulation (Habibzadegah-Tari, Byer and Khan, 2006).
ROS such as superoxide and hydrogen peroxide have also been shown to mediate 
TNF-a induced MCP-1 (CCL2) expression in endothelial cells (Chen et al, 2004). 
Elevated MCP-1 (CCL2) expression might be responsible for increased monocyte 
infiltration in the injured kidney. Sung et al demonstrated enhanced MCP-1 (CCL2) 
expression in rat kidney during ischemia - reperfusion injury and that it is mediated by 
NF-kB activation and oxidative stress (Sung et al, 2002).
Inhibition of MCP-1 (CCL2) signalling in ischemic renal injury have shown to have a 
protective role (Furuichi et al, 2003). Takaya et al have shown that ERK signalling is 
involved in BSA-induced MCP-1 (CCL2) expression in mProx cells (Takaya et al, 
2003). Takahashi et al have also suggested JNK- and kB-dependent pathways 
regulate MCP-1 (CCL2) synthesis and also found NAC could suppress MCP-1 (CCL2) 
production (Takahashi et al, 2008).
NAC has been shown to reduce the expression of MCP-1 (CCL2) in a rat model of 
acute pancreatitis (Xu, Wu and Shen, 2008).
6.6 NAC:
NAC has been known to have mucolytic and antioxidant properties. Beneficial effects 
of N-acetyl-cysteine on renal injury triggered by ischemia and reperfusion have been 
shown by Di Giono (Di Giorno et al, 2006).
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NAC has also been shown to protect kidneys against oxidative damage, reversed 
oxidant responses and protected rat renal proximal tubules from in vitro simulated 
reperfusion injury (Sehirli et al, 2003).
Antonicelli et al investigated the effect of Nacystelyn, a recently developed lysine salt 
of NAC upon interleukin IL-8 (CXCL8) release and the activation of the redox- 
sensitive transcription factors AP-1, NF-kappaB, and C/EBP in a human alveolar 
epithelial cell line (A549). Nacystelyn at 5 mM enhanced intracellular glutathione 
(GSH) after 4 h and abolished hydrogen peroxide induced IL-8 (CXCL8) release in 
A549 cells. This was associated with inhibition of NF-kB. (Antonicelli et al, 2002)
Ayvaz et al have reported the benefit of NAC in intestinal ischemic injury as well as, 
reperfusion in rats (Ayvaz et al, 2009). NAC in combination with Erdosteine has also 
been shown to improve the biochemical results of IR injury (Erdogan et al, 2006). 
Nitescu et al have shown NAC improves kidney function, and reduces renal interstitial 
inflammation, in rats subjected to renal IRI. These effects were associated with 
increased renal glutathione levels, and decreased plasma ascorbyl concentrations, 
suggesting that NAC attenuates renal and systemic oxidative stress in this model 
(Nitescu et al, 2006).
Jiang et al have shown NAC inhibits the induction IL-8 (CXCL8) gene and protein by 
LPS via suppression of NF-kB activation in human uterine smooth cells (Jiang et al, 
2008).
Wuyts et al have shown in human airway smooth muscle cells, adding NAC 
decreased IL-17 induced IL-8 (CXCL8) production. The clinical significance of these in 
vitro findings for prevention or treatment of chronic rejection after lung transplantation 
remains to be investigated (Wuyts et al, 2004).
Zhang et al have proposed that NAC exerts its protective effect in part by directly 
scavenging ROS and in part via ERK1/2 activation. In their study NAC could protect
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HK-2 cells against the toxic effects of a hydroquinone metabolite (Zhang, Lau and 
Monks, 2011).
Ueno et al have recently showed the role of NAC in controlling oxidative stress 
against osteoblasts and have suggested further in vivo studies to test its therapeutic 
potential as a local antioxidative stress drug (Ueno et al, 2011).
6.6.1 Clinical use of NAC: Despite many favourable results in the lab models, NAC 
has not been used widely in the clinical world. So far it has shown some clinical 
benefit in preventing DGF and contrast nephropathy.
6.6.2 Prevention of DGF:
Danilovic et al have shown clinical benefit of NAC in renal transplant recipients. Use of 
NAC resulted in reduced rate of DGF and better renal function was seen for up to one 
year (Danilovic et al, 2011).
NAC administration has also showed an improvement in the histopathological findings 
of ischemia/reperfusion damages (Ayvaz et al, 2009). Donor pre treatment with NAC 
has been shown to preserve renal metabolism and improve outcomes of l/R injured 
kidney transplants (Fuller et al, 2004). Fuentes et al have shown NAC treatment in 
patients with stable renal function after transplantation increased high-density 
lipoprotein cholesterol and antioxidant molecules in relation to glutathione peroxidase, 
with a positive influence on renal function (Ruiz Fuentes et al, 2008).
6.6.3 Prevention of contrast nephropathy:
Prophylactic oral administration of NAC, along with hydration, prevents the reduction 
in renal function induced by iopromide, a nonionic, low-osmolality contrast agent, in
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patients with chronic renal insufficiency (Tepel et al, 2000), (Shalansky et al, 2005; 
Birck et al, 2003). Briguori et al have reported that NAC was better than fenoldopam 
mesylate to prevent contrast agent-associated nephrotoxicity (Briguori et al, 2004).
6.7 Cold storage:
Kidneys are kept in cold storage prior to implantation for variable time periods. This 
period is crucial in limiting the ischemic damage. The preservative fluids used during 
this time provide a unique therapeutic window where anti oxidants like NAC can be 
utilised to prevent and control IRI.
Several research groups have made significant advances in this area by testing a 
range of compounds as additives to preservation solutions to improve cellular or 
tissue function during cold storage or after transplantation. Some reports suggest that 
the addition of bioflavonoids and trophic factor supplementation to preservation 
solutions should be explored further because these compounds prevented lipid 
peroxidation, mitochondrial dysfunction, and loss of cell viability during cold storage of 
porcine and canine renal tubular cells (Ahlenstiel et al, 2006; Kwon et al, 2007). 
Salhudeen et al have shown cold storage modulated the expression of intrinsic 
antioxidants, particularly that of mitochondrial Mn-SOD, and addition of extrinsic 
antioxidants to University of Wisconsin solution markedly enhanced its ability to 
protect cells against cold-induced structural and functional injury (Salahudeen, Joshi 
and Jenkins, 2001).
The addition of the antioxidant deferoxamine to the University of Wisconsin (UW) 
preservation solution has been shown to improve glomerular filtration rate and 
decrease cell death in a syngeneic rat kidney transplant model (Huang et al, 2003).
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Adding mitoquinone, a mitochondria-targeted antioxidant, to University of Wisconsin 
preservation solution could offer protection against cold storage injury (Mitchell et al, 
2011).
Cold storage slows down metabolic reactions to preserve organ quality while allowing 
time for recipient selection and transport. Although this procedure is extremely 
valuable, cold storage has been shown to cause vasoconstriction, tubular and 
endothelial injury, and cell death which can result in discardment of kidneys. Fortifying 
the storage solution with deferoxamine or preconditioning the donor kidneys with 
hemeoxygenase-1 may prove viable clinical strategies to limit cold ischemic injury 
(Salahudeen, 2004).
6.8 Oxidative stress markers in renal biopsies:
This experimental work on renal allograft biopsies was aimed to determine the 
oxidative stress occurring after transplantation. Donor pre-implantation biopsies 
provided a unique opportunity to detect oxidative stress occurring due to IRI and thus 
link up with the IRI in a cell culture model.
Renal allograft biopsies are routinely performed to evaluate renal dysfunction. The 
procedure generally has a low complication rate. The following complications have 
been reported: gross hematuria 3.5%, perirenal hematomas 2.5%, arterio-venous 
fistulas 7.3% and vasovagal reactions 0.5%. Major complications requiring invasive 
procedures such as blood transfusions or urinary catheterisation are seen in 1% of 
cases (Schwarz et al, 2005).
Some authors have advocated renal biopsies for prognostic purpose. Schwarz et al 
have shown that morphological changes of CAN expressed as tubular atrophy and 
interstitial fibrosis precedes the decline of renal functional (Schwarz et al, 2005). Other
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authors have suggested its use to detect subclinicai rejection (Thierry et al, 2011), 
(Henderson, Nankiveii and Chapman, 2011).
A total of 61 biopsies were analysed and the following oxidative stress enzymes were 
detected by western blot: Catalase 60kd, MnSOD 25kd, CuZnSOD 23kd, Thioredoxin 
reductase 55 kd Thioredoxin (2b1) 12kd, and Thioredoxin 62kd.
Upregulation of most of the anti-oxidant enzymes was detected in biopsies obtained 
from deceased donor kidneys prior to transplantation. MnSoD was expressed more in 
donor kidneys, acute rejection and cyclosporine toxicity. CuZnSoD was also elevated 
in donor and acute rejection biopsies. Catalase was elevated in donor and acute 
rejection biopsy samples. Thioredoxin was elevated in donor biopsies while 
thioredoxin reductases were elevated in donors, acute rejection and cyclosporine 
toxicity. Ischemic injury and related oxidative stress is possibly the reason for the 
elevation in these enzymes. However, due to lack of adequate control biopsies the 
results were difficult to interpret.
6.8.1 Catalase:
Catalase has been investigated by several authors in biopsy material and Reuter et al 
conducted proteome analysis of rat renal allografts and found that the expression of 
catalase was downregulated (Reuter et al, 2010). Dutkiewicz also found that 
polymorphism in the catalase gene is associated with DGF in kidney allograft 
recipients (Dutkiewicz et al, 2010).
Granqvist et al showed that antioxidative defence was higher in the tubulointerstitial 
compartment than in the glomerular cells and found a reduction in glomerular 
enzymes catalase and glutathione peroxidase-3, and -4 in nephritic kidneys. The 
tubular gene expression was downregulated for catalase, glutathione peroxidase-3, 
and thioredoxin reductase-1 and -2 (Granqvist et al, 2010).
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Cadaveric kidneys when compared to live donor kidneys have exhibited a distinctly 
different set of anti oxidant genes originating from the tubulointerstitial compartment 
(Kainz et al, 2004). The deceased donor kidneys have long periods of cold storage 
resulting in hypoxic damage and thus oxidative stress. Our results from such kidneys 
confirm this phenomenon as biopsies taken from these kidneys showed an increase in 
oxidative stress enzymes like MnSod, CuZnSod, catalase and the thioredoxin system. 
Donor kidneys from recipients with impaired allograft function also showed activation 
of genes mainly belonging to the functional classes of immunity, signal transduction, 
and oxidative stress response (Kainz et al, 2007).
6.8.2 SOD:
CuZnSOD comprises ~90% of total SOD activity in a eukaryotic cell (Liu et al, 2004). 
Mahmoud et al have also reported an increase in CuZnSoD from cattle liver biopsies 
after inducing oxidative stress (Abd Ellah et al, 2009).
Salahudeen et al have shown that genetic expression of mitochondrial MnSOD, but 
not of cytosolic CuZnSOD or of glutathione peroxidase, increased with cold exposure, 
suggesting mitochondria as a cellular source of free radicals and activation under cold 
injury (Salahudeen et al, 2000).
MnSoD over expression in renal tubular cells has been shown to protect against high- 
glucose-induced oxidative stress (Munusamy and MacMillan-Crow, 2009). Chen et al 
showed increased mRNA levels of CuZnSOD and MnSOD enzymes in the cortex and 
medulla of rats subjected to hypoxia (Chen et al, 2003).
Saba et al have investigated the role in cold preservation of MnSoD and mitochondrial 
injury. Short term cold l/R resulted in inactivation of MnSOD. These data suggest that 
compounds designed to prevent early mitochondrial injury in kidneys that undergo
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cold preservation would significantly improve renal function and graft survival following 
transplantation (Saba, Munusamy and Macmillan-Crow, 2008).
Loss of mRNA of catalase and GPX may be the first markers of alterations in cellular 
redox in ischemia-reperfusion injury. The mRNA for MnSOD was upregulated at all 
time points of ischemia-reperfusion injury suggest that antioxidant genes are not 
coordinately expressed during ischemia-reperfusion and that the differential loss of 
antioxidant enzymes may be the contributing factor(s) towards the heterogeneous 
renal tissue damage as a result of ischemia-reperfusion induced oxidative stress 
(Dobashi et al, 2000).
Some authors have also suggested that mitochondrial dysfunction is an early event in 
a rat model of allotransplant and may play a causative role in the development of 
chronic allograft nephropathy (MacMillan-Crow et al, 2001).
6.8.3Thioredoxin system;
Thioredoxin reductase has been reported to be prominently expressed in the proximal 
tubules of rodent kidneys (Rundlof et al, 2000). Kasuno et al reported secretion of 
thioredoxin from proximal tubules into urine during renal ischemia/reperfusion and 
suggested it may have a protective effect against renal ischemia/reperfusion injury 
(Kasuno et al, 2003). Conterato et al have also found elevated thioredoxin reductase 
activity after exposure to lead acetate in rat kidneys along with other anti- oxidant 
enzymes like catalase and superoxide dismutase (Conterato et al, 2007).
In proximal tubules nuclear and luminal localization was detected for Trx1 after IRI. 
The cytosolic TrxR1 was detected in all tubular segments, especially strong in distal 
convoluted tubules and thin segments of the inner medulla. Trx2 was diffusely 
expressed in all regions of the kidney. After IRI, Trx2 immunoreactivity increased in 
the mTAL segments and in the lumen of thin segments in the inner medulla .TrxR2,
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which was primarily detected in connective tissue in the sham group, showed a 
segment-specific increase after IRI, most notably in the lumina and epithelial cells of 
distal convoluted tubules.
Strong immunoreactivity for TrxR2 in luminal compartments was also observed in the 
inner medulla (Godoy et al, 2011).
6.8.4 Cyclosporine nephrotoxicity:
Several of the biopsy specimens studied were taken from patients with cyclosporine 
nephrotoxicity. Histology is characterised by tubular vacuolation and an ATN like 
picture. Results from western blot assay revealed that all of the anti oxidant enzymes 
tested were elevated in cyclosporine nephrotoxicity. Thioredoxin reductase in 
particular showed the maximum elevation although other enzymes like MnSoD, 
CuZnSoD, Catalase and Thioredoxin 12kda were also elevated.
Cyclosporine nephrotoxicity is manifested by renal insufficiency due to glomerular 
disease and abnormalities in tubular function. Several mechanisms have been 
proposed for cyclosporine A-induced nephrotoxicity, such as sodium retention, renal 
vasoconstriction, renal hypoxia, as a consequence of renal vasoconstriction, 
stimulation of the renin-angiotensin system, activation of the sympathetic nervous 
system, impaired synthesis of nitric oxide, and increased growth factor-BI (Atessahin, 
Ceribasi and Yilmaz, 2007; Lee et al, 2001; Sanchez-Pozos et al, 2010).
Oxidative stress has been implicated in cyclosporine nephrotoxicity. Increase in ROS 
generation and lipid peroxidation has been shown to affect renal function and 
interstitial fibrosis (Burdmann et al, 2003; Atasoyu et al, 2006).
Buffoli et al have reported reduction of both oxidative stress and increased iNOS and 
NF-kB expression induced by Cyclosporine with use of red wine polyphenol (Buffoli et 
al, 2005).
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NAC treatment significantly protected animals against cyclosporine induced structural 
and functional impairment of kidneys implicating the role of oxidative stress in the 
pathogenesis of CsA-induced nephrotoxicity (Tariq et al, 1999).
Magendramani et al have shown that cyclosporine nephrotoxicity is mediated through 
increased expressions of inducible nitric oxide synthase (iNOS), NF-/cB and matrix 
metalloproteinase-2 which was altered by an anti-oxidant S-allylcysteine thereby 
rendering protection to the kidney cells (Magendiramani et al, 2009).
6.9 Limited clinical benefit of anti oxidants:
It is generally thought that reactive oxygen species (ROS) are involved in a wide 
variety of diseases, including ischemia-reperfusion, cancer and various types of 
inflammation. Despite this widespread involvement of ROS there is a lack of 
widespread use of anti oxidants in clinical use.
A/-acetylcysteine, despite the growing evidence of benefit, has very limited used only 
for treating over-doses of acetaminophen and for improvement of bronchial mucous 
fluidity which might affect thiol proteases (Jones, 1998).
Edaravone has been used for the treatment of acute cerebral infarctions (Edaravone 
Acute Infarction Study Group, 2003), (Houkin et al, 1998).
Recombinant Cu, Zn-SOD and Mn-SOD have been produced, but their plasma half- 
lives are very short, limiting their use (Somack, Saifer and Williams, 1991).
In a porcine model anti oxidants used including NAC failed to show any benefit 
(Kuntscher et al, 2007). Although the therapeutic use of antioxidants is now 
widespread, some of these have been shown to be successful, but many appear to 
have no or little benefit, in terms of being beneficial to general health or in disease 
prevention (Suzuki, 2009).
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Many anti-oxidants show strong positive effects in the laboratory, but only a few of 
these drugs are used as anti-oxidants in humans. Some plausible reasons for this are 
that because ROS production occurs ubiquitously in aerobic cells and chemical 
reactivity of ROS takes place in a non-specific manner; to find statistically significant 
differences in different cells or tissues is difficult.
Human blood and tissues already contain an abundance of anti-oxidants. Moreover, 
many anti-oxidative enzymes are readily induced by many cytokines and stresses. A 
preconditioning phenomenon in ischemia-reperfusion could be due to the production 
of inducible antioxidative enzymes, such as MnSOD, while xanthine oxidase is 
induced which is a potential source of ROS. Because of this, when anti-oxidative 
drugs are administered to humans, their clinical benefits are frequently difficult to 
verify (Suzuki, 2009). Also even if expression of enzyme or protein is seen it may not 
necessarily result in an increase in activity (Weydert and Cullen, 2010).
In clinical terms Kubal et al did not find any correlation between hypoxia times and 
mitochondrial complex activities and DGF (Kubal et al, 2009).
6.10 Future directions:
This study has clearly shown that HK-2 cells are responsive to various physiological 
stimuli like hydrogen peroxide and cytokines. Oxidative stress is possibly involved in 
the various responses seen. N-Acetyl cysteine was able to block these responses 
effectively further reinforces the importance of oxidative stress. The challenge remains 
to reproduce these results in clinical situations and perhaps further similar studies in 
vivo model will be beneficial. We had used high dosage of MAC (lOmMol), this 
dosage maybe difficult to use for clinical purposes so further studies with reduced 
dosage titration of NAG is suggested. High dosage of NAC can be delivered in cold 
perfusion fluids.
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The cell culture model has proven to be successful in studying oxidative stress and 
cyclosporine is another agent which could be studied further here. The clinical 
biopsies have also shown an increase in oxidative stress in cyclosporine toxicity 
group.
The renal allograft biopsies also showed us that oxidative stress was involved in 
various acute injuries occurring within the allograft. However due to lack of control 
biopsies the results could not be interpreted effectively. Future studies involving renal 
allograft biopsies must include a control sample from normal kidney.
Acute injuries like cold ischemia in donor biopsies were associated with oxidative 
stress further correlation with warm and cold ischemia times are recommended which 
may pave the way for therapeutic use of NAC.
6.11 Conclusions:
DGF is an important clinical outcome after kidney transplantation, and one that needs 
to be addressed by funding agencies, trialists and clinicians. DGF is both an outcome 
of a renal allograft and a predictor for its subsequent course. In an era of a 
tremendous shortage of kidneys for transplantation, every effort should be made to 
improve the survival of the transplanted kidneys in the recipient. Therefore, it is 
imperative that we implement strategies to reduce the incidence of DGF in an effort to 
improve long-term graft survival.
Elucidation of the pathophysiology of renal ischaemia and reperfusion injury has 
contributed to the development of strategies to decrease the rate of delayed graft 
function, focusing on donor management, organ procurement and preservation 
techniques, and pharmacological agents (vasodilators, antioxidants, anti-inflammatory 
agents). Several new drugs show promise in animal studies in preventing or
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ameliorating ischaemia-reperfusion injury and possibly delayed graft function, but 
definitive clinical trials are lacking.
Because ROS production is very common and the human body has an abundant 
capacity for producing anti-oxidants, it is difficult to obtain statistical differences in 
trials designed to evaluate an anti-oxidative drug. Additional resources will be needed, 
if we are to use anti-oxidants in human clinical settings, e.g. drug delivery to a specific 
region, appropriate setting of evaluation goals in clinical trials, new approaches to 
understanding the details of anti-oxidative systems.
In spite of these drawbacks, the additional use of anti-oxidants in clinical settings is 
clearly warranted, and could contribute positively to human health. It is generally 
thought that ROS are involved in a wide variety of diseases, including ischemia- 
reperfusion, cancer and various types of inflammation.
Histological evaluations before transplantation may enable the identification of organs 
unsuitable for single implantation (Navarro et al, 2011) but such evaluation of 
oxidative stress enzymes is not done in routine practice.
Based on the 2009 Organ Procurement and Transplantation Network/Scientific 
Registry of Transplant Recipients Annual Report, 16% of kidneys recovered from 
potential deceased donors were discarded because of cold ischemia times, biopsy 
findings, or the inability to locate a recipient (Klein et al, 2010).
IRi is now acknowledged as a key target to improve graft outcome, particularly 
through ex-vivo interventions during transport. This phase is indeed an underused 
therapeutic window, although few studies have highlighted its importance. The 
present results show that NAC is a drug with potential for altering the oxidative stress 
and chemokine induction thus reducing the cellular injury during ischemia reperfusion 
injury. This potent drug warrants further investigation.
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